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The goal of conformal radiotherapy (CRT) is to deliver the prescribed dose to a 
volume that closely conforms to the three-dimensional (3D) target volume while the 
dose to adjacent healthy tissues or organs at risk is minimized. Because the position 
of the target volume can change substantially both within and between radiation 
treatment fractions the fourth dimension, namely time, needs to be addressed as 
well. The consideration of time in the 3D treatment process is referred to as four-
dimensional (4D) radiotherapy. Variations in the target volume position with time 
are mainly due to organ motion and patient and beam set-up deviations. Changes in 
the target volume position that occur within a treatment fraction are referred to as 
intra-fraction variation. Respiratory and cardiac motion are the main contributors 
to intra-fraction positional variations of thoracic and abdominal target volumes.
In routine clinical practice thoracic and abdominal tumors are irradiated while 
the patient breathes freely. To account for target volume variations in size, shape 
and position and patient and beam set-up deviations, an empirical 3D margin is 
added to the clinical target volume to obtain the planning target volume (1, 2). 
The 3D margin is often derived from respiratory motion measurements in patients 
representative of the general population. Such a margin is not tailored to the 
individual patient and will therefore be suboptimal in most cases. Alternatively, 
the tumor motion in a specific patient can be determined as part of the treatment 
planning procedure. Fluoroscopy is most widely used for this purpose. However, 
tumors are often poorly visualized using this imaging modality. In addition, 
fluoroscopic data cannot directly be related to the treatment planning computed 
tomography (CT) data. 
Recently, several strategies to reduce the impact of respiratory motion have been 
explored. Two distinct techniques have been used: either the patient is allowed to 
breathe freely or not. In the case of free breathing techniques, irradiation can be 
gated to a part of the respiratory cycle where tumor motion is minimal (3), or the 
moving target can be tracked by the continuous radiation beam (4). Both strategies 
have the potential to improve the therapeutic ratio, but require challenging imaging 
and respiratory monitoring efforts that will also pose a substantial demand on 
departmental logistics. The second technique is based on voluntary (5) or forced 
breath hold strategies (6). These breath holding techniques may also improve the 
therapeutic ratio, but likewise demand challenging technical efforts. Many lung 
cancer patients may have difficulties to tolerate repeated breath holds. In addition, 
because the radiation fraction needs to be delivered in small portions, the treatment 
duration will substantially increase. The latter drawback also applies for gated 
treatment, but not for tumor tracking CRT.
Next to respiratory motion, the other main contributor to thoracic and upper 
abdominal intra-fraction target volume movement is cardiac motion. Ekberg et 
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al. (7) studied lung tumor movement in 20 patients by fluoroscopy and found 
significant cardiac motion of tumors situated close to the heart. Ross et al. (8) 
studied intrathoracic neoplasm movement in 20 patients by an ultra-fast CT 
scanner. Five out of six hilar lesions showed significant lateral motion with cardiac 
contraction. These studies did not qualitatively separate respiratory from cardiac 
tumor motion. Seppenwoolde et al. (9) on the other hand did separate between 
these motion effects. They studied the 3D motion of markers implanted in or 
near lung neoplasms using a real-time tumor tracking system consisting of two 
fluoroscopy image processor units. They detected cardiac tumor motion in seven 
out of the 20 studied patients. The amplitude of this motion was 1– 4 mm, mostly 
in the lateral direction. 
This thesis describes the development of strategies to account for respiratory 
and cardiac motion for each patient individually in CRT. State-of-the-art imaging 
techniques have been used for this purpose. Embedded in the general aim of the 
thesis, strategies to determine and incorporate cardiac motion in the target volume 
have been explored by studying the clinical feasibility of CRT for the treatment of 
coronary artery in-stent restenosis, as an alternative to intravascular brachytherapy. 
The results of the studies to define coronary artery stents as a potential target 
volume are described in chapters 2 to 5. Chapter 2 describes how coronary artery 
stent motion during the cardiac cycle can be determined by biplane angiography 
for definition of a potential CRT target volume. Chapter 3 reports on a comparison 
of different options to define a smallest feasible potential target volume for external 
beam radiation treatment of coronary artery stents using angiographic data. Chapter 
4 describes how multislice spiral computed tomography (MSCT) can be used to 
determine and incorporate cardiac motion of coronary artery stents for definition 
of a potential CRT target volume. Chapter 5 reports the results of a treatment 
planning study for such a MSCT-defined target volume. Chapters 6 and 7 deal with 
strategies to determine and account for respiratory lung tumor motion in CRT. 
Chapter 6 describes how respiratory motion of such tumors can be determined by 
MSCT. Chapter 7 reports on a comparison between a 3D and a 4D MSCT imaging 
strategy to account for respiratory lung tumor motion. 
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Abstract
Three-dimensional reconstructions of 19 coronary artery stents from biplane 
angiograms were used for measurement of the volume through which the stents 
traversed during the cardiac cycle. This volume, less than 0.8% of the whole heart 
volume in all patients, represents a target volume for high-precision radiotherapy 
to treat coronary artery in-stent restenosis.
17
Coronary stent traversed volume during the cardiac cycle defined by angiograms
Introduction
Several randomized clinical trials have demonstrated that intracoronary γ- and 
β-radiation, as an adjunct modality to angioplasty, are potent new therapies 
for coronary artery in-stent restenosis (4,12). Nevertheless, intracoronary 
brachytherapy suffers from several radiobiological, clinical, physical and logistic 
disadvantages that may be addressed by the use of external beam radiotherapy 
(EBRT). Its noninvasive nature, improved dose homogeneity over a range of 
tissue depths, flexibility to optimize the time of treatment in relation to target 
cell proliferation following percutaneous transluminal coronary angioplasty, dose 
fractionation and use of radiosensitizers are examples of the advantages EBRT 
offers over intracoronary brachytherapy. However, animal studies on the effects 
of EBRT – targeted at virtually the entire heart – for inhibition of coronary artery 
restenosis reported conflicting results, and also without exception reported cardiac 
tissue side effects (5,8,11). Although these animal studies include a recent report 
that a single, high dose of 21 Gy EBRT targeted at the whole heart can significantly 
inhibit coronary artery in-stent restenosis (11), clinical implementation of such 
a treatment may only be feasible when side effects are prevented. Hence high-
precision EBRT has been suggested as a strategy to explore (2,5,6,11). The purpose 
of this study was to use three-dimensional (3D) reconstructions of coronary artery 
stents from biplane angiograms for measurement of the volume through which the 
stents traversed during the cardiac cycle in an attempt to define a target volume for 
high-precision EBRT to treat coronary artery in-stent restenosis. 
Materials and methods 
Patients
Nineteen coronary artery Wallstents (Schneider, Bülach, Switzerland) in 19 patients 
(14 men, five women; mean age 58 ± 9 years; mean weight 82 ± 11 kg) in sinus 
rhythm who underwent conventional angiography were studied. The stented 
arteries included the left circumflex (LCx; n = 3), the left anterior descending (LAD; 
n = 7) and the right coronary artery (RCA; n = 9). The mean stent diameter was 3.8 
± 0.6 mm, and the mean stent length was 29.9 ± 10.9 mm. The University Hospital 
Ethical Review Board approved the study, and informed consent was obtained 
from all participants.
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Acquisition and processing of X-ray images
Biplane X-ray filming (BICOR, Siemens, Forchheim, Germany) during a breathhold 
was performed at 25 frames per second (0.04-s temporal resolution). For calibration 
of the X-ray geometrical settings, a calibration cube (axis length 40 mm) and a 
flat calibration grid were filmed after the procedure. Films and the simultaneously 
recorded electrocardiogram (ECG) were stored in DICOM format (8 bits, 512 x 
512 pixels) on a compact disk. From the film recordings, biplane sets of contrast-
free frames clearly showing the stent and covering at least one R-R interval of the 
cardiac cycle were selected and stored on a personal computer. Consequently, the 
number of selected sets of frames was dependent on the heart rate. The borders 
of the stent were contoured manually in the selected sets of frames. For contour 
determination, custom-made software was used, incorporating standard zooming 
and contrast optimization features to aid recognition of image details. In the 
calibration images, the edges of the calibration cube and a 5 x 5-cm area of the grid 
were indicated.
Three-dimensional reconstruction
The method to 3D reconstruct coronary artery stents uses the algorithm previously 
described to 3D reconstruct the centerline of an intravascular ultrasound catheter 
(10). The centerline of the stent in each biplane view was derived from the stent 
contours. By using these centerlines the 3D centerline can be reconstructed. On 
the 3D centerline 64 equidistant points were defined. At each point a circle was 
constructed perpendicular to the centerline assuming a circular cross section. The 
diameter of the circles was derived from the mean 2D stent diameter in both views 
corrected for the local magnification factors. Accuracy of the spatial reconstruction 
of the centerline was determined by the root mean square (RMS) of the distances 
between the 2D projections of the 64 equidistant points of the 3D reconstructed 
centerline and corresponding points in the actual drawings. 
Data analysis
The length of the reconstructed centerline, i.e. the stent length, was measured in 3D 
as the cumulative distance between the 64 points along the reconstructed centerline. 
Three-dimensional displacement of the proximal and distal stent ends throughout 
the R-R interval of the cardiac cycle was measured relative to the firstly defined 
end-diastolic location (R peak). By using the latter measurements, the accuracy by 
which the stent returned to the same location at the end of the R-R interval was 
calculated (Figure 1). 
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Figure 1. Graph showing an example of the three-dimensional displacement of a left anterior descending coronary artery 
stent (proximal end) throughout the cardiac cycle. The arrow depicts the accuracy by which the stent returned to the same 
location at the end of the R-R interval for two successive cardiac cycles; this spatial distance has no specifically defined direction.
The stent volume was calculated from the stent length and the mean diameter. 
By defining 32, equidistant, points on each stent circular cross section, a total of 
2048 (64 x 32) stent surface points were obtained. The stent traversed volume 
(STV) during the R-R interval of the cardiac cycle was determined by mapping 
the 2048 surface points of each stent reconstruction to corresponding cubes (0.5 
mm) in a 3D voxel space. Also, the gaps between successive stent reconstructions 
were mapped to 3D by connecting all corresponding surface points with a spline 
interpolation algorithm. In addition, all voxels enclosed inside the stent surface 
map were detected by a fill algorithm and added to the STV. The sum of all mapped 
voxel cubes represented the STV. To demonstrate the accuracy of the reconstruction 
and STV algorithm, a straight stainless-steel tube with a diameter of 4.0 mm and a 
length of 25.3 mm was filmed when moving along a straight path over a distance of 
34.7 mm. The stent volume and STV were 0.3 cm3 and 3.8 cm3, respectively. 
An estimate of the whole heart volume (WHV) was calculated by the equations 
as have been reported by Erikson et al. (1).
Statistical analysis
All values are expressed as mean ± SD. One-way analysis of variance followed by 
the Dunnett’s post hoc test was used to compare the means of the maximum stent 
end displacements, stent volumes, stent traversed volumes and WHV estimates 
for the three stented coronary artery groups, i.e. the LCx, LAD and RCA. Linear 
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regression analysis was used to test the relationship between the STV and stent 
volume for LAD and RCA stents within the range of data points. The Student’s 
t-test was used to test the difference between the slopes of the two regression lines. 
A value of P < 0.05 was considered significant.
Results
The average RMS distance between the biplane back-projected 3D reconstructed 
stent centerlines and the actual 2D centerlines was less than 0.5 mm for each patient 
(mean 0.37 ± 0.08 mm). 
The accuracy by which the stent returned to the same location at the end of the 
R-R interval of the cardiac cycle was 1.5 ± 1.4 mm for the proximal stent end 
and 1.6 ± 1.6 mm for the distal stent end. For 10 patients with stents in the LCx 
(n = 3), LAD (n = 3) and RCA (n = 4), data of two successive cardiac cycles was 
investigated. The accuracy by which the proximal and distal stent end returned to 
the same location at the end of the first R-R interval was 1.7 ± 1.3 mm and 1.4 ± 
1.3 mm, respectively, and 1.6 ± 1.0 mm and 1.6 ± 1.4 mm at the end of the second 
R-R interval, respectively.
The mean maximum displacement of the proximal stent end during the R-R 
interval of the cardiac cycle for the LCx, LAD and RCA, respectively, was 12.8 ± 
4.4, 8.7 ± 1.3 and 24.6 ± 4.9 mm (P < 0.001); the mean maximum displacement 
of the RCA was significantly higher than that of the LCx (P = 0.044) and LAD (P 
< 0.001). The mean maximum displacement of the distal stent end during the R-R 
interval of the cardiac cycle for the LCx, LAD and RCA, respectively, was 13.9 ± 
0.6, 8.6 ± 1.4 and 19.3 ± 7.9 mm (P = 0.006); the mean maximum displacement 
of the LAD significantly differed from that of the LCx (P < 0.001) and RCA (P = 
0.009).
The measured stent volume and STV, as derived from the stainless-steel tube, 
was 0.3 and 3.9 cm3, respectively, which corresponded to a relative error of –5.8% 
and + 3.7%, respectively. For the LCx, LAD and RCA, the mean stent volume 
was 0.26 ± 0.01, 0.28 ± 0.12 and 0.44 ± 0.19 cm3, respectively (P = 0.094). The 
mean STV was 2.3 ± 0.6, 1.5 ± 0.4 and 5.7 ± 2.7 cm3 for the LCx, LAD and RCA, 
respectively (P = 0.001); the mean STV of the RCA was significantly higher than 
that of the LCx (P = 0.014) and LAD (P = 0.005). Linear regression analysis was 
used to evaluate the relationship between the STV and stent volume for the LAD 
and RCA data points (Figure 2). The slope of the regression line was significantly 
higher (P = 0.01) for the RCA (STV = 12.84 (± 6.22) x stent volume + 0.04 (± 2.94); 
r2 = 0.85; P < 0.001) than for the LAD (STV = 2.25 (± 2.97) x stent volume + 0.88 
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(± 0.89); r2 = 0.44; P = 0.73), i.e. corresponding stent volumes result in higher stent 
traversed volumes during the cardiac cycle in the case of RCA compared to LAD 
stents. No regression line was drawn for the LCx, because only three data points 
were available.
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Figure 2. Scatter diagram showing the relationship between the stent traversed volume (STV) and stent volume. u, left 
circumflex; n, left anterior descending; l, right coronary artery.
The stent traversed volumes were also related to estimates of the WHV. The mean 
estimated WHV was 1226 ± 225 cm3. The STV represented less than 0.8% of the 
WHV in all patients. There was no significant difference between the means of the 
WHV estimates for the LCx, LAD and RCA (P = 0.214).
Discussion
The present study demonstrates that 3D reconstruction of coronary artery stents 
from biplane angiograms allowed measurement of the STV. This volume, a 
combined measure of the stent size and cardiac motion effect during the cardiac 
cycle, represented less than 0.8% of the whole heart volume in all patients. The 
definition of the STV represents a successful attempt to define a target volume for 
high-precision EBRT to treat coronary artery in-stent restenosis.
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The observed relationship between the STV and stent volume, i.e. corresponding 
stent volumes result in higher stent traversed volumes during the cardiac cycle in 
the case of RCA compared to LAD stents (Figure 2), concurs with the calculated 
differences between the mean maximum displacements of the LAD and RCA and 
previous reports on cardiac motion of coronary arteries (7,13). Although based on 
a limited number of data points, the results probably reflect the different anatomic 
courses and different orientation of the LAD versus the RCA with respect to the 
main direction of cardiac motion. As opposed to the LAD, the stented segments of 
the RCA run through the atrioventricular sulcus in the basal plane of the heart. Since 
cardiac motion increases from apex to base (7,9), the RCA stents will show greater 
motion. In addition, the anatomic course of the RCA has an almost perpendicular 
orientation to the main direction of cardiac motion, i.e. from basal plane to apex 
(9), while the LAD has a more parallel orientation to the main direction of cardiac 
motion, which may also partially explain our observations.
Because of its superior image quality and temporal resolution, biplane X-ray 
angiography allows measurement of the STV, however it does not provide imaging 
data compatible with EBRT treatment planning software. An additional computed 
tomography (CT) scan would need to be performed to address this problem. To 
allow clinical implementation in high-precision EBRT treatment planning, the CT 
scan and angiographic films, of both the patient and calibration cube, would need 
to be performed by using the same high-precision coordinate system. The position 
of the patient and calibration cube during the CT scan would then need to be 
exactly reproduced during X-ray angiography. The stereotactic body frame (SBF) 
can be used for this purpose. The SBF is essentially a box with shallow sides and 
an open top in which the patient lies, held firmly in a vacuum pillow. It provides a 
coordinate system external to the patient’s body and thereby enables noninvasive, 
accurate and reproducible patient immobilization for stereotactic diagnostic 
localization and radiotherapy (3,14).
The fact that respiratory motion was not yet accounted for is a limitation of this 
study. This subject warrants a future study to establish a precise and reproducible 
internal target volume. Also only one, particularly radio-opaque, type of coronary 
artery stent was studied.
In conclusion, the results demonstrate that 3D reconstruction from biplane 
angiograms of stents in the three major epicardial coronary arteries allows the 
definition of a target volume for high-precision EBRT to treat coronary artery 
in-stent restenosis. The small dimension of the target volume warrants further 
exploration of this strategy.
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Abstract
Purpose: High-precision external beam radiotherapy (EBRT) has been suggested as 
a potential alternative to endovascular brachytherapy for the treatment of coronary 
artery in-stent restenosis. The purpose of our study was to investigate and compare 
different options to define a smallest feasible target volume.
Methods and materials: The cardiac motion of 17 coronary artery stents in 17 
patients was studied by use of biplane conventional angiography, recorded during 
breath-hold. Each stent was reconstructed in three dimensions by use of biplane 
sets of frames covering an entire cardiac cycle. The volume traversed by the stent 
during the entire or part of the cardiac cycle was determined. Four options to 
define the stent-traversed volume (STV) as a target for high-precision EBRT were 
investigated. 
Results: The mean STV during the entire cardiac cycle was 3.5 cm3; the STV 
represented less than 1% of the heart volume in all patients. The STV during the 
diastolic and systolic phase resulted in a mean reduction of 26.6% and 29.1%, 
respectively, compared with the STV during the entire cardiac cycle. The smallest 
STV, measured during a 160-ms interval within the cardiac cycle, resulted in a 
mean maximal reduction of 75.9% compared with the STV during the entire 
cardiac cycle.
Conclusions: The STV during the entire cardiac cycle represents a small potential 
target volume for high-precision EBRT. A significant reduction of this target volume 
is possible in case of definition during a selected interval within the cardiac cycle. 
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Introduction
Endovascular brachytherapy is a potent therapeutic option for patients with 
coronary artery in-stent restenosis (1, 2). Nevertheless, external beam radiotherapy 
(EBRT) may offer radiobiological, physical, clinical, and logistic advantages over 
endovascular brachytherapy. The effectiveness of EBRT by delivery of a high single 
dose of 21 Gy to inhibit coronary artery in-stent restenosis has recently been reported 
in a porcine model. However, cardiac tissue side effects were also reported (3). The 
side effects in the latter study and in other studies (4, 5), which also investigated the 
use of EBRT targeted at the whole porcine heart, concurs with the well-established 
observation that the volume of heart irradiated is directly correlated with the 
risk of radiation-induced heart disease (6). Clinical implementation of EBRT as a 
potential alternative to intracoronary brachytherapy demands maximum effort to 
prevent such side effects, which can only be achieved by delivering EBRT to the 
smallest feasible target volume, such as a coronary artery stent. Hence exploration 
of high-precision EBRT has been suggested (3, 5, 7, 8). Because various strategies 
are available to reduce respiratory motion and novel strategies are being pursued 
(9), the main problem to overcome for such a treatment technique is to account for 
cardiac motion of coronary artery stents. Applying radiation to a volume covering 
successive stent locations enlarges the smallest possible target volume defined by 
the stent itself, but is likely to be required for practical application. Optimization 
of such a target volume requires data on cardiac motion of the stent in relation 
to time. For this purpose, the electrocardiogram (ECG) is useful as a means to 
indirectly infer the stent’s continuous position throughout the cardiac cycle. 
It has been recently shown that both biplane angiography (10) and multislice 
spiral computed tomography (MSCT) (11) synchronized to the ECG allow for 
definition of the volume through which coronary artery stents traverse during the 
entire cardiac cycle; the stent-traversed volume (STV) was reported to comprise 
less than 1% of the heart volume (HV). Reduction of this potential target volume 
for high-precision EBRT may be achieved by defining shorter intervals within the 
cardiac cycle. To date, this strategy has only been suggested (12, 13) and has not 
– to our knowledge – been investigated. The highest temporal resolution that can 
be provided by MSCT currently still is too low for a thorough investigation of the 
aforementioned strategy given the fast movement of coronary arteries; only X-ray 
angiography is suitable for such an investigation.
The purpose of this study was to use biplane X-ray angiograms to investigate 
and compare several options to define a smallest feasible target volume for high-
precision EBRT of coronary artery in-stent restenosis.
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Methods and materials 
Patients
Seventeen coronary artery Wallstents (Schneider AG, Bülach, Switzerland) in 17 
patients in sinus rhythm (13 men, 4 women) were studied by biplane angiography. 
The patients’ ages were 57 ± 10 years (mean ± 1 standard deviation [SD]), and 
their weight was 84 ± 11 kg. The stented vessels included the left circumflex (n = 
3), the left anterior descending (n = 6), and the right coronary artery (n = 8). The 
stent diameter was 3.8 ± 0.6 mm, and the stent length was 31.9 ± 10.5 mm. The 
Erasmus MC Ethical Review Board approved the study, and informed consent was 
obtained from all participants.
Acquisition and processing of biplane angiography images
Biplane conventional X-ray angiography (BICOR, Siemens AG, Forchheim, 
Germany) of the stented coronary artery segment during breath-hold was performed 
at 25 frames/s. From the film recordings, biplane sets of contrast-free frames clearly 
showing the stent and covering an entire cardiac cycle plus seven additional frames 
before and after the R-peak in the ECG were selected and stored on a personal 
computer. The borders of the stent were contoured manually in the selected sets 
of frames (Figure 1). For contour determination custom-made software was 
used incorporating standard zooming and contrast optimization features to aid 
recognition of image details.
Figure 1. Lateral angiographic view of a contoured left circumflex coronary artery stent.
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Three-dimensional reconstruction of coronary artery stents and stent traversed volumes
The method to three-dimensionally (3D) reconstruct coronary artery stents uses the 
algorithm previously described to 3D reconstruct the centerline of an intravascular 
ultrasound catheter (14). The centerline of the stent and its diameter in each biplane 
view was derived from the stent contours. By use of these centerlines, the 3D 
centerline can be reconstructed. The stent length was determined by measurement 
of the length of the reconstructed centerline. By combining the angiographically 
determined stent diameter with the 3D centerline, a cylindrical 3D stent body was 
reconstructed. Calculation of the stent volume was performed by determination of 
all voxels in 3D space (0.5 mm cubic resolution) encompassed by the cylindrical 
stent body. 
For the moving stent, positions in between two successive locations were 
interpolated at a spatial resolution less than 0.5 mm. Combining all voxels traversed 
by the moving stent with those encompassed by the stent itself at its first and final 
position of a certain trajectory defined the STV (Figure 2).
A BA B
Figure 2. Diagram shows the definition of the stent-traversed volume during the entire cardiac cycle for a right coronary 
artery stent. (a) Voxels encompassed by the stent itself at its first and final position. (b) All voxels traversed by the moving stent 
including those encompassed by the stent itself at its first and final position of a certain trajectory.
Data analysis
Three-dimensional displacement and velocity of the proximal and distal stent ends 
throughout the cardiac cycle was measured relative to the first defined end diastolic 
location (R-peak). Four options to define the target volume for high-precision 
EBRT were investigated: 
1. The STV during the entire cardiac cycle.
2. The STV during the diastolic phase of the cardiac cycle. The diastolic phase was 
defined by use of velocity plots (Figure 3), and its duration was measured. 
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3. The STV during the systolic phase of the cardiac cycle. The systolic phase was 
defined by use of velocity plots (Figure 3), and its duration was measured.
4. The smallest STV during 160-480-ms intervals when moving by 40-ms steps 
through the cardiac cycle (Figure 4). For each patient, the time between the first 
defined R-peak and the time point at which the smallest STV was observed was 
expressed relative to the duration of the RR interval. 
For the latter three options – that is, high-precision EBRT during intervals shorter 
than the cardiac cycle – the elongation factor of the irradiation time relative to 
delivering the same dose during the entire cardiac cycle was calculated.
An estimate of the HV was calculated by the equations as have been reported by 
Erikson et al. (15).
Statistical analysis
All values are expressed as mean ± SD. The paired t test was used to compare the 
STVs between the different options to define the target volume. A value of p < 0.05 
was considered significant.
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Figure 3. The velocity of a right coronary artery distal stent end throughout the cardiac cycle. The typical velocity plot is 
triphasic with peaks during the systole (I), early diastole (II), and atrial contraction (III) (20). These peaks enable differentiation 
between the systolic and diastolic phase of the cardiac cycle, as is also depicted in the diagram. 
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Figure 4. The stent-traversed volume (STV) for a right coronary artery (RCA) stent throughout the cardiac cycle for a 160- 
(black line) and 400-ms (gray line) interval. The point that corresponds to the smallest STV for the respective intervals is depicted 
by a dot. Also shown is the velocity of the proximal stent end (dotted line) throughout the cardiac cycle. The pattern of the graph 
line for the 160-ms interval and velocity is quite similar, in contrast to the graph line for the 400-ms interval and velocity. The 
time between the first defined R-peak and the time point within the cardiac cycle at which the smallest STV was observed was 
measured (arrow).
Results
The STV during the entire cardiac cycle was 3.5 ± 2.6 cm3. For all patients, the STV 
represented less than 1% of the HV. The estimated HV was 1264 ± 212 cm3. The 
duration of the entire cardiac cycle was 0.96 ± 0.18 s.
The STV during the diastolic phase of the cardiac cycle was 2.5 ± 1.9 cm3, which 
corresponded to a reduction of 26.6 ± 11.7% in comparison to that during the 
entire cardiac cycle. For all patients, the STV during the diastolic phase represented 
less than 0.5% of the HV. The duration of the diastolic phase was 0.59 ± 0.14 s. 
In comparison to high-precision EBRT of the STV during the entire cardiac cycle, 
targeting the STV during the diastolic phase would increase the irradiation time by 
a factor of 1.7 ± 0.2.
The STV during the systolic phase of the cardiac cycle was 2.4 ± 1.6 cm3, which 
corresponded to a reduction of 29.1 ± 10.3% in comparison to that during the 
entire cardiac cycle. For all patients, the STV during the systolic phase represented 
less than 0.5% of the HV. The duration of the systolic phase was 0.39 ± 0.08 s. 
In comparison to high-precision EBRT of the STV during the entire cardiac cycle, 
targeting the STV during the systolic phase would increase the irradiation time by 
a factor of 2.5 ± 0.4.
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The smallest STV during 480-ms, 400-ms, 320-ms, 240-ms, and 160-ms intervals 
within the cardiac cycle was 1.5 ± 1.1 cm3, 1.5 ± 1.0 cm3, 1.2 ± 0.9 cm3, 0.9 ± 0.6 
cm3, and 0.7 ± 0.4 cm3, respectively, which corresponded to a reduction of 46.5 ± 
16.3%, 54.1 ± 15.9%, 61.8 ± 14.4%, 68.6 ± 13.0%, and 75.9 ± 10.0%, respectively, 
in comparison to the STV during the entire cardiac cycle. For all patients, the STV 
during all intervals represented less than 0.3% of the HV, reaching a minimum of 
0.06 ± 0.03% for the shortest interval. The time point at which the smallest STV 
was observed was at 54 ± 18%, 51 ± 17%, 52 ± 16%, 54 ± 16%, and 54 ± 17% of 
the RR interval for the 160–480-ms intervals, respectively. In comparison to high-
precision EBRT of the STV during the entire cardiac cycle, targeting the STV during 
a 160–480-ms interval within the cardiac cycle would increase the irradiation time 
by a factor ranging between 6.2 ± 1.0 and 2.1 ± 0.3. Intervals larger than 480 ms 
resulted in a steep rise of the corresponding STV. Therefore larger intervals were 
not investigated. The smallest possible STV, that is, the stent volume itself, was 0.4 
± 0.2 cm3.
The STV steadily decreased significantly with each option to define the target 
volume (i.e., from the STV measured during the entire cardiac cycle to the smallest 
STV measured during a 160-ms interval within the cardiac cycle) with exception of 
the difference between the STV during the diastolic and systolic phase.
Discussion
Because of its superior image quality and temporal resolution, biplane angiography 
was chosen to investigate four different options to define the STV during all or part 
of the cardiac cycle. It is shown that biplane angiography allowed definition of 
significantly smaller potential target volumes when compared with the STV during 
the entire cardiac cycle. Measurement of the STV during the diastolic and systolic 
phase of the cardiac cycle resulted in a mean reduction of 26.6% and 29.1%, 
respectively, in comparison to the STV during the entire cardiac cycle. The smallest 
STV during the shortest investigated interval of 160 ms within the cardiac cycle 
resulted in a mean maximal reduction of the STV by 75.9% in comparison to the 
STV during the entire cardiac cycle. 
Because most, if not all, coronary artery stents will not be visible on conventional 
portal films, an alternative strategy is needed for treatment setup verification 
and correction. Systems combining biplane X-ray imaging with an image-guided 
linear accelerator have recently been introduced in radiotherapy and may use the 
findings of the current study. The real-time tumor-tracking radiotherapy system, 
for instance, consists of two pairs of diagnostic X-ray systems, an image processor 
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unit, a gating control unit, and an image display unit. The system recognizes the 
position of a 2.0-mm gold marker, which is inserted in or near a body tumor 30 
times per second. The linear accelerator is gated to irradiate the tumor only when 
the marker is within a given tolerance from its planned coordinates relative to 
the isocenter (16). An exactly similar strategy would not be applicable for ECG-
triggered high-precision EBRT of coronary artery stents because the radiopacity 
of current stents will not allow real-time 3D reconstruction. It neither is likely 
that markers could be added to stents considering space and biocompatibility 
restrictions. An adaptation of real-time tumor-tracking radiotherapy on the other 
hand seems feasible. To use the optimum cardiac window as determined in this 
study, respiratory motion would need to be reproducibly accounted for during high-
precision EBRT treatment planning and treatment. Either respiratory triggering or 
a breath-hold technique can be used for this purpose. Cardiac triggering combined 
with a breath-hold technique would be preferable from a technical point of view. 
However, the latter is notoriously irreproducible without a spirometry forced 
breath-hold (9). Active breathing control may therefore be useful because it allows 
temporary and reproducible immobilization of internal thoracic structures by 
implementing breath-hold at a predefined phase within the breathing cycle (17). 
During such breath-holds, ECG-triggered pulses of irradiation can be applied during 
a specific interval within successive cardiac cycles. The 3D stent locations during 
the interval selected during treatment planning would need to be determined before 
irradiation from biplane images while the patient maintains the predefined breath-
hold. The STV can then be defined using these 3D stent locations, which at most 
will take about 1 min, and could subsequently be targeted by ECG-triggered pulses 
during the selected interval within successive cardiac cycles. Whether additional 
reduction of the STV may be achieved for any interval by taking into account 
the specific shape of the STV and direction of cardiac motion in selecting beam 
directions needs further study. In any case, it is anticipated that the aforementioned 
irradiation strategy will significantly reduce the 3D planning target volume margin 
that includes all treatment uncertainties. Coronary arteries have been reported to 
return to the same position from heartbeat to heartbeat with great precision during 
breath-hold (18). However, it remains to be investigated whether the time point at 
which the smallest STV was measured for intervals within the cardiac cycle can be 
reproducibly inferred from the ECG.
Because biplane X-ray imaging data are not directly compatible with EBRT 
treatment planning systems, computed tomography data would be needed. 
Moreover, accurate treatment planning calculations would benefit from computed 
tomography images that clearly show cardiac vessel anatomy including stents 
besides other thoracic structures. ECG-gated MSCT is suitable for this purpose 
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because it allows reliable noninvasive coronary artery imaging (19). MSCT scans for 
treatment planning would be acquired during a selected interval within the cardiac 
cycle while the patient maintains the predefined breath-hold. Because the highest 
temporal resolution MSCT currently allowed is about 200 ms, some enlargement of 
the minimal STV determined for an interval of, for example, 160 ms, is anticipated. 
Nevertheless, it seems a fair anticipation that MSCT will allow reasonably accurate 
treatment planning. Furthermore, the number of MSCT scanners installed around 
the world is growing exponentially and the gap between the temporal resolution 
of MSCT and biplane X-ray imaging as used in this study will be closed even 
further in the near future. Alternatively, the angiographically defined STV could be 
superimposed on planning computed tomography images that would only need to 
allow identification of the external patient contour, lung and heart tissues.
Although ECG-triggered irradiation of target volumes defined during intervals 
of, for example, 160 ms, may be essential in an attempt to minimize potential 
radiation-induced heart disease and is within the specifications of state-of-the-art 
linear accelerators with ultrafast beam-on times, such a strategy will technically 
be quite challenging. To what extent targeting the STV during part instead of 
during the entire cardiac cycle would result in a proportionate reduction of the 
volume of heart exposed to the prescribed dose needs to be studied. ECG-triggered 
irradiation during small intervals within the cardiac cycle will also demand great 
logistic efforts. When high-precision ECG-triggered EBRT would be applied during 
160-ms intervals, irradiation time will increase by a mean maximal factor of 6.2 
in comparison to treatment during the entire cardiac cycle. Delivery of 10 Gy, 
for instance, with a dose rate of 600 MU/min takes 3–5 min for one static beam. 
Considering irradiation time only, ECG-triggered EBRT with one static beam 
during 160-ms intervals would therefore increase treatment duration to 18–30 
min at least. This would impose a heavy burden on the logistics of a radiotherapy 
unit; especially when additional logistically imposing factors are considered such 
as dose fractionation, treatment with multiple beams to minimize the volume of 
heart receiving high dose as much as possible and repeated preparations of cardiac 
triggering combined with active breathing control.
In conclusion, biplane X-ray imaging allows definition of the STV during the 
entire cardiac cycle, which represents a small potential target volume for high-
precision EBRT. A significant reduction of this target volume is possible by selecting 
an interval within the cardiac cycle. ECG-triggered EBRT of such small target 
volumes for treatment of coronary artery in-stent restenosis seems feasible but will 
require complex technical and logistic efforts. 
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Abstract 
Purpose: To measure the effect of cardiac motion on coronary artery stent position 
during the cardiac cycle as a first step toward exploring the feasibility of stereotactic 
external beam radiation therapy targeted at restenotic stented coronary arteries.
Methods and materials: The three-dimensional (3D) position of eight coronary 
artery stents in 8 patients immobilized in a stereotactic body frame was studied 
noninvasively by single-breathhold ECG-gated multislice spiral computed 
tomography (MSCT) during 10 retrospectively selected phases, equally distributed 
throughout the R-R interval of consecutive cardiac cycles. The volume encompassing 
all measured 3D positions of the stent was measured.
Results: Stent volumes measured by MSCT closely agreed with measurements 
by quantitative coronary angiography (r > 0.99). The mean of the maximum 3D 
stent center of mass displacement between any two phases during the cardiac cycle 
for all eight coronary arteries was 7.5 mm (range 3.3–20.5 mm) in the lateral 
direction, 8.6 mm (range 2.7–21.6 mm) in the ventrodorsal direction, and 8.2 mm 
(range 2.5–19.7 mm) in the craniocaudal direction. As was anticipated, the volume 
encompassing all measured 3D positions of the stent represented only a fraction of 
the whole heart volume in all patients, i.e., less than 0.6 %.
Conclusions: ECG-gated MSCT allowed the measurement of the volume 
encompassing multiphase 3D positions of coronary artery stents during the cardiac 
cycle. This volume, a measure of the cardiac motion effect on coronary artery stent 
position during the cardiac cycle, represents a moving gross target for stereotactic 
external beam radiation therapy.
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Introduction
In-stent restenosis after successful intracoronary stent implantation is a serious 
medical condition. Despite the use of repeated interventional procedures, > 50% of 
these patients have recurrent in-stent restenosis (1). Several randomized clinical trials 
have demonstrated that intracoronary γ- and β-radiation, as an adjunct modality 
to intervention, are potent new therapies for in-stent restenosis (2-4). For example, 
Leon et al. (2) have demonstrated that the need for repeated revascularization of 
the target lesion was reduced by 42 %. However, new phenomena arise: late stent 
thrombosis caused by radiation-induced delay in endothelialization over the stent 
struts or by the effects of radiation on endothelial-cell function may emerge (2). 
In addition endovascular brachytherapy suffers from several biologic, physical, 
and logistic disadvantages that – in theory – could be bypassed by the use of 
external beam radiation therapy (EBRT). Among the advantages EBRT offers over 
endovascular brachytherapy are its noninvasive nature, improved dose homogeneity 
and accuracy over a range of tissue depths, flexibility to optimize the time of 
treatment in relation to target cell proliferation after percutaneous transluminal 
coronary angioplasty, dose fractionation, and use of radiosensitzers. Moreover, 
EBRT has demonstrated reduced postangioplasty restenosis in peripheral vessels 
(5, 6). To date, no studies have reported beneficial effects of EBRT in coronary 
arteries. Marijianowski et al. (7), for instance, reported that EBRT in pig coronary 
arteries could exacerbate arterial healing, evidenced by the presence of interstitial 
and perivascular fibrosis in the myocardium. The authors argued that this result 
might be explained by their irradiation technique; virtually the whole heart received 
the prescribed dose of 14 Gy, while it is well established that the volume of heart 
irradiated is directly correlated with the risk of radiation-induced cardiotoxicity 
(8). Hence stereotactic EBRT, e.g., targeted at the volume encompassing all three-
dimensional (3D) positions of a coronary artery stent during the cardiac cycle, has 
been suggested as a potential future direction to pursue (9, 10). Such a strategy 
will present several challenging problems such as measurement of the cardiac 
and respiratory motion effect on coronary artery stent position, and precise and 
reproducible setup accuracy. 
The purpose of this study was to determine whether electrocardiographically 
(ECG)-gated multislice spiral computed tomography (MSCT) of stented coronary 
arteries in patients immobilized in a stereotactic body frame (SBF) allowed us to 
measure the effect of cardiac motion on coronary artery stent position during the 
cardiac cycle. This is a first step toward exploring the feasibility of stereotactic 
EBRT targeted at restenotic stented coronary arteries.
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Methods and materials 
Patients
The University Hospital Ethical Review Board approved this study. All participants 
gave informed consent. Between February 1 and April 11, 2000, eight consecutive 
patients (two women and six men, age range 48–75 years, mean age 59 years) 
referred by the cardiologist for evaluation of coronary artery stenoses by contrast-
enhanced MSCT, were entered in this study. A single stent was studied in each 
patient, one in the left circumflex (LCx), five in the left anterior descending (LAD) 
and two in the right coronary artery (RCA). The following eight, stainless-steel 
stents were used: three NIROYAL (Medinol, Maple Grove, MN), two ACS Multi-
link Duet (Guidant, Santa Clara, CA), one Genius (EuroCor, Bonn, Germany), one 
BX Velocity (Cordis, Warren, NJ), and one Terumo (Terumo, Tokyo, Japan). The 
mean nominal stent length was 23 mm (range 16–38 mm). The median interval 
between stent implantation and the MSCT scan was 19.5 days (range 3-89 days). 
All patients were in sinus rhythm with mean heart rates between 57 and 93 beats 
per minute. 
Stereotactic body frame
The SBF (Elekta, Crawley, West Sussex, UK) has been described previously in detail 
(11). Briefly, on the table of the MSCT scanner, patients were positioned in the SBF 
on a vacuum pillow filled with plastic pellets. The pillow was shaped to the patient’s 
body by allowing air to enter. The air was evacuated out of the pillow by a manual 
pump to obtain a rigid body mold. The 3D coordinate system, manufactured to be 
visualized on CT images and mounted inside the SBF side walls, was subsequently 
aligned to the MSCT gantry laser. By using the level control and a spirit level, the 
SBF was finally also accurately aligned to the horizontal plane.
Multislice computed tomography: Data acquisition and image reconstruction
The MSCT scanner (SOMATOM Volume Zoom, Siemens AG, Forchheim, 
Germany) with a 500-ms rotation time and simultaneous acquisition of four slices, 
has been described previously (12-14). Briefly, 20 s after the i.v. injection of 150 
mL of contrast agent (iomeprol, Iomeron 350 mg iodine/mL, Bracco, Milan, Italy), 
the scan was initiated with simultaneous registration of the patient’s ECG signal. 
Contrast-enhancement was used to enable identification of all major epicardial 
vessels, which is essential for future dosimetric studies. Within a single end-
inspiratory breathhold (range 27– 41 s, mean 35 s), the entire heart volume was 
scanned with a 4 x 1-mm collimation protocol (effective slice thickness 1.25 mm). 
The pitch (table feed per rotation divided by the single collimated slice thickness) 
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was set at 1.5 for heart rates below 80 beats per min (7 patients) and 2.0 for 
faster heart rates (1 patient). The raw CT data were transferred to an off-line PC 
workstation for ECG-gated image reconstruction by dedicated work-in-progress 
software (Siemens Cardio Package, Siemens AG) implemented in MATLAB V5.3 
(MathWorks Inc, Natick, MA). Isocardiophasic, overlapping (increment 0.8 mm), 
axial slices (field of view 80 mm; matrix 512 x 512) were reconstructed during 
10 retrospectively selected, 250-ms-long intervals (partial scan-reconstruction 
techniques, which apply a 90–180º reconstruction algorithm, improve the temporal 
resolution to 250 ms) equally distributed throughout the R-R interval of the 
consecutive cardiac cycles. The phases were determined relative to the previous R 
peak for each cardiac cycle separately, with starting points given as a percentage of 
the R-R interval (Figure 1). 
Quantitative coronary angiography (QCA)
By use of the interventional angiograms, the mean stent diameter was determined in 
a single end-diastolic image with an edge detection quantitative angiography system 
(CAAS II, Pie Medical, Maastricht, The Netherlands) (15). The empty catheter was 
used for calibration. The stent volume, computed by πr2l (r = mean QCA stent 
radius, l = nominal stent length provided by the manufacturer), is referred to as the 
QCA stent volume and represents an estimate of the true stent volume. The primary 
reason to use the nominal stent length was to avoid the effects of foreshortening 
(measurement of a shortened stent when the angiographic plane of view is not 
exactly parallel to the length of the stent) associated with QCA.
Figure 1. Strategy to determine 3D stent center of mass displacements; image datasets were reconstructed during 10 cardiac 
phases. 
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Data analysis
The reconstructed DICOM (digital imaging and communications in medicine) 
images were transferred to a XKnife 4.0 3D radiosurgery planning workstation 
(Radionics, Burlington, MA). Cardiac motion and local metal artifacts around 
the stent struts were observed; the stent wall was manually contoured across its 
centerline at a level of around 400 Hounsfield units in all 10 MSCT datasets of 
each patient (Figure 2a). By use of the contours, the radiosurgery planning software 
constructed stent volumes. 
A B ESV
WHV
Figure 2. (a) Multislice CT image of a left anterior descending coronary artery stent contoured in black (arrow). (b) Whole 
heart volume (WHV) and volume encompassing all measured 3D positions (ESV) of a left anterior descending coronary artery 
stent during the cardiac cycle.
The dataset that visually yielded optimal image quality was used to measure the 
reference stent volume with use of custom-made software developed by one of the 
authors. This volume was considered to represent the MSCT stent volume, and 
was consecutively matched by 3D translation and rotation with the other nine 
volumes to measure the stent center of mass displacements throughout the cardiac 
cycle. The matches were visually verified to preclude displacements attributable to 
differences in stent volume. For each patient, the stent volumes of all datasets were 
copied to one image. The volume around all 10 stent positions was encompassed as 
a measure of the cardiac motion effect during contraction (systole) and relaxation 
(diastole).
This volume was compared with the whole heart volume (including the pulmonary 
trunk, ascending aorta, and superior vena cava beginning on the cross-section in 
which the left auricle emerged, and then following the external contour of the 
heart caudally), which was contoured slice-by-slice in an additionally reconstructed 
dataset (Figure 2b).
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Statistical analysis
Regression analysis was used to determine the correlation between QCA and 
MSCT stent volume measurements. The agreement between measurement by QCA 
and MSCT was quantified using the differences between observations made using 
the two methods on the same subjects (16). 
Results
The imaging procedure with the SBF was performed successfully and without 
complications in all patients. ECG-gated MSCT provided adequate image quality 
for multiphase visualization of coronary artery stents. 
A close linear correlation (r > 0.99) between QCA and MSCT measurements of 
stent volumes was found (Figure 3a). MSCT consistently overestimated the QCA 
stent volumes (Figure 3b); the between-method difference was 46.6 ± 1.4 mm3 
(SD). In an attempt to explain the consistent overestimation, the stent volumes 
were also measured in images reconstructed by use of a smoother kernel with a 
higher signal-to-noise ratio. Again, a close linear correlation (r > 0.99) was found 
(Figure 3a). MSCT consistently slightly underestimated the QCA stent volumes 
(Figure 3b); the between-method difference was -5.4 ± 2.7 mm3 (SD).
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Figure 3. Correlation between stent volumes measured by quantitative coronary angiography and multislice CT. (a) 
Regression analysis to determine linear correlation. The dotted line indicates equality. (b) Between-method difference plotted 
against the average of corresponding measurements (16). The dotted horizontal lines indicate the mean between-method 
difference ± 2 standard deviations. ° = stent volumes measured in images reconstructed by the original kernel; o = stent 
volumes measured in images reconstructed by the smoother kernel. 
The mean of the maximum 3D stent center of mass displacement between any 
two phases during the cardiac cycle for all eight coronary arteries was 7.5 mm 
(range 3.3–20.5 mm) in the lateral direction, 8.6 mm (range 2.7–21.6 mm) in 
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the ventrodorsal direction, and 8.2 mm (range 2.5–19.7 mm) in the craniocaudal 
direction (Figure 4). The mean of the volume encompassing all measured 3D stent 
positions was 1.4 cm3 (range 0.4–3.8 cm3). The mean whole heart volume was 
740 cm3 (range 683–828 cm3). As was anticipated, the volume encompassing all 
measured 3D positions of the stent represented only a fraction of the whole heart 
volume in all patients, that is, less than 0.6 %.
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Figure 4. Representative 3D displacement pattern throughout the cardiac cycle of a left anterior descending coronary 
artery stent center of mass. The position of the stent center of mass was measured during 10 cardiac phases equally distributed 
throughout the R-R interval. All plots are normalized to 0 %, i.e., normalized to the R peak that reflects the onset of ventricular 
activation. The x-dimension designates lateral displacement, the y-dimension ventrodorsal displacement, and the z-dimension 
craniocaudal displacement. Positive x, y and z values correspond to left, dorsal, and cranial displacements, respectively. The 
amplitude of the displacement in each dimension reflects the maximum displacement between any two phases during the 
cardiac cycle (19).
Discussion
Because of the potential advantages of EBRT over endovascular brachytherapy, 
stereotactic EBRT, e.g., targeted at the volume encompassing all 3D positions 
of a coronary artery stent during the cardiac cycle, has been suggested as a 
potential future direction to pursue in cardiovascular radiation medicine for in-
stent restenosis (9, 10). The present study demonstrates that ECG-gated MSCT 
allowed the measurement of the volume encompassing multiphase 3D positions of 
a coronary artery stent during the cardiac cycle, as a measure of the cardiac motion 
effect. As was anticipated, this volume represented only a fraction of the whole 
heart volume in all patients. The definition of this moving gross target volume 
(GTV) represents a first step toward exploring the feasibility of stereotactic EBRT 
targeted at restenotic stented coronary arteries. To our knowledge, measurement of 
such a moving GTV, by using imaging data indexed in time with the ECG, has not 
been reported previously.
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However, further refinement is needed, e.g., of the stent volume measurement by 
MSCT, and other challenging problems need to be overcome, such as accounting 
for the effect of respiratory motion on coronary artery stent position during the 
cardiac cycle and for stereotactic setup accuracy. The SBF used for this study may 
be useful to partly overcome these challenging problems as it provides precise and 
reproducible 3D setup accuracy of less than 5 mm (SD) (11, 17). 
A limitation of this study relates to the measured stent positions that in fact 
represent an average position during each cardiac phase, because the current 250-
ms temporal resolution of MSCT allows considerable coronary artery motion. On 
the other hand, MSCT allows retrospectively ECG-gated multiphase spiral data 
acquisition, offers high spatial resolution, low image noise, and high tissue contrast 
compared to other noninvasive cardiac imaging techniques such as electron-beam 
computed tomography and magnetic resonance imaging (12–14). Furthermore, 
MSCT data are compatible with EBRT planning systems. Because of the small 
number of patients, we could not provide stent center of mass displacement and 
encompassing volume data for each of the major epicardial coronary arteries 
separately, i.e., LCx, LAD and RCA. As opposed to the LAD, the RCA runs 
through the atrioventricular sulcus in the basal plane of the heart. Because cardiac 
motion increases from apex to base (18), higher volumes encompassing all 3D 
positions of a coronary artery stent during the cardiac cycle in the case of RCA 
compared to LAD stents are to be expected. In addition, the anatomic course of 
the RCA has an almost perpendicular orientation to the main direction of cardiac 
motion, i.e., from basal plane to apex (18), whereas the LAD has a more parallel 
orientation to the main direction of cardiac motion. This difference in orientation 
of the RCA and LAD in relation to the main direction of cardiac motion will 
also add to a difference in volumes encompassing all 3D positions of RCA and 
LAD stents during the cardiac cycle. Although the number of patients studied was 
small, the observed range, direction, and variation of 3D coronary artery stent 
displacements were in agreement with previously reported data (19). The effect of 
respiratory motion on coronary artery position during the cardiac cycle was not 
yet accounted for in this study, but will be addressed in future studies. This effect 
may be accounted for by use of active breathing control, which allows temporary 
and reproducible immobilization of internal thoracic structures by implementing 
a breathhold at a preselected phase in the breathing cycle (20), or by respiratory-
gating techniques. 
In conclusion, the results represent a first step toward exploring the feasibility of 
stereotactic EBRT of restenotic stented coronary arteries, i.e., the definition of a 
moving GTV. We believe this strategy deserves further investigative exploration.
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Abstract 
Purpose: Several drawbacks of endovascular brachytherapy for the treatment of 
coronary artery in-stent restenosis may be addressed by high-precision external 
beam radiotherapy (EBRT). The dosimetric characteristics of both treatment 
techniques were compared.
Methods and materials: The traversed volume of 10 coronary artery stents during 
the cardiac cycle was determined by electrocardiographically gated multislice spiral 
CT in 10 patients. By use of this traversed volume, high-precision EBRT treatment 
plans were generated for stents in the left circumflex (LCx), left anterior descending 
(LAD), and right coronary artery (RCA). The maximum dose to the nontargeted 
major coronary arteries was determined and compared to similar data calculated 
for endovascular brachytherapy. 
Results: High-precision EBRT targeted at LCx stents contributed a mean maximum 
dose (Dmax) of 83.5% (range 71.6–95.3%) and 16.3% to the LAD and RCA, 
respectively. Targeted LAD stents contributed a mean Dmax of 39.3% (range: 
14.5–94.8%) and 5.2% (range: 0–13.4%) to the LCx and RCA, respectively. 
Targeted RCA stents contributed a mean Dmax of 6.2% (range: 0–12.4%) and 5.8% 
(range: 0–11.5%) to the LCx and LAD, respectively. Endovascular brachytherapy 
targeted at LCx stents contributed a mean Dmax of 1.7% (range: 0.7–2.7%) and 
1.0% (range: 0.6–1.4%) to the LAD and RCA, respectively. Targeted LAD stents 
contributed a mean Dmax of 5.2% (range: 0.5–11.4%) and 0.7% (range: 0.4–1.1%) 
to the LCx and RCA, respectively; targeted RCA stents contributed a mean Dmax 
of 0.3% (range: 0.2–0.5%) and 0.2% (range: 0.1–0.3%) to the LCx and LAD, 
respectively.
Conclusions: Although the doses distributed throughout the heart were higher for 
high-precision EBRT compared to endovascular brachtytherapy, they are expected 
to be clinically irrelevant when nontargeted major coronary arteries are not closely 
situated to the targeted vessel segment. These encouraging results warrant further 
investigation of high-precision EBRT as a potential alternative to endovascular 
brachytherapy for the treatment of coronary artery in-stent restenosis. 
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Introduction
Endovascular brachytherapy as an adjunct to percutaneous transluminal coronary 
angioplasty (PTCA) has demonstrated promising results in several randomized 
clinical trials for the treatment of coronary artery in-stent restenosis (1, 2). However, 
it is also associated with a number of drawbacks that may be addressed by external 
beam radiotherapy (EBRT). Dose fractionation, synchronization with cell kinetics, 
and improved dose homogeneity over a range of tissue depths are examples of the 
potential advantages EBRT offers over endovascular brachytherapy. So far, animal 
studies on the effects of EBRT targeted at virtually the entire heart for inhibition 
of coronary artery restenosis consistently reported myocardial inflammation 
and fibrosis (3–5). These studies reported also conflicting results with regard to 
neointima formation, i.e., exacerbated (4), unchanged (3), and reduced restenosis 
(5). Although the latter study provides evidence for the effectiveness of whole heart 
EBRT at 21 Gy to inhibit neointima formation in stented porcine coronary arteries, 
the observed cardiac tissue side effects will hamper clinical implementation of 
such a treatment technique. Hence, exploration of high-precision EBRT has been 
suggested (3, 5–7), which requires first of all a small target volume, such as a 
coronary artery stent. Recently, single breath hold electrocardiographically gated 
multislice spiral computed tomography (MSCT) was used in a successful attempt to 
define the volume through which coronary artery stents traverse during the cardiac 
cycle, as a potential target for high-precision EBRT. The stent-traversed volume 
(STV) during the cardiac cycle was reported to comprise only a fraction – that is, 
less than 0.6% – of the whole heart volume (WHV) in 8 patients (8). 
The purpose of this study was to use the coronary artery STV during the cardiac 
cycle as a target for high-precision EBRT treatment planning and to compare the 
dose distributions to those obtained for endovascular brachytherapy. 
Methods and materials 
Patients
Imaging data for 10 patients (3 women and 7 men, ages 61 ± 8 years [mean ± 1 
standard deviation], age range: 48–75 years) who underwent clinical investigation 
of coronary artery in-stent restenosis by MSCT were used for this study. A single 
stent in one of the three major coronary arteries was studied in each patient: 2 
in the left circumflex (LCx), 6 in the left anterior descending (LAD), and 2 in the 
right coronary artery (RCA). The implanted stents included 1 Genius (EuroCor, 
Bonn, Germany), 2 ACS Multi-link Duet (Guidant, Santa Clara, CA), 3 NIROYAL 
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(Medinol, Maple Grove, MN), 2 BX Velocity (Cordis, Warren, NJ), 1 Terumo 
(Terumo, Tokyo, Japan), and 1 R stent (Orbus, Ft. Lauderdale, FL). The nominal 
stent length was 20.9 ± 7.4 mm (range: 13–38 mm). The median interval between 
stent implantation and the MSCT scan was 15 days (range: 3-89 days). All patients 
were in sinus rhythm. The institution’s ethical review board approved the study. All 
participants gave informed consent.
Stereotactic body frame
Patients were rigidly positioned on the couch of the MSCT scanner in a stereotactic 
body frame (Elekta, Crawley, West Sussex, UK) on a vacuum pillow perfectly 
shaped to the patient’s body. Details have been described elsewhere (8, 9).
MSCT: Data acquisition 
A contrast-enhanced MSCT scan (Somatom Plus 4 Volume-Zoom, Siemens AG, 
Forchheim, Germany) of the entire heart, using a 4 x 1.0-mm collimation protocol, 
was performed during a single breath hold (10–12). Synchronized to the recorded 
electrocardiogram, transverse slices were retrospectively reconstructed on an off-
line workstation (Work-in-progress Siemens Cardio Package, Siemens AG). Because 
the spiral CT data was acquired continuously, a stack of overlapping slices can be 
reconstructed at any point. Ten isocardiophasic volume datasets were created by 
positioning the 250-ms reconstruction window at 0%, 10%, and 20–90% of the 
cardiac cycle (8).
MSCT: Data analysis
The stent wall was manually contoured along the line through its center in each of 
the 10 MSCT datasets by using an XKnife RT 1.03 (Radionics, Burlington, MA) 
three-dimensional (3D) radiosurgery treatment planning system. Stent volumes 
were constructed by the treatment planning software. All contoured stent volumes 
were copied into a diastolic dataset. The volume around all 10 stent positions was 
encompassed as a measure of the STV during the cardiac cycle – that is, the cardiac 
motion effect during contraction and relaxation (8). 
External beam radiotherapy dose distributions
High-precision EBRT treatment plans were generated for the traversed volume during 
the cardiac cycle of each coronary artery stent by use of the treatment planning system. 
For this purpose, the targeted stent, the remainder of the targeted coronary artery, 
the two nontargeted major coronary arteries, and the heart volume were contoured 
in the diastolic MSCT dataset. The planning target volume (PTV) was obtained by 
adding a 3D craniocaudal margin of 10 mm and a ventrodorsal and lateral margin 
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of 5 mm to account for the effect of respiration during breath hold and for setup 
errors. With the entire body contour taken into account, the dose was prescribed to 
the 80%-encompassing isodose surface, by using three noncoplanar arcs with 6-MV 
photons (Figure 1). First, a class solution was created that entailed one arc in the 
sagittal plane and two transversal arcs – with a sufficient gap to avoid overlap with 
the sagittal arc – using circular cones in conjunction with the jaws of the accelerator. 
Subsequently, by varying the weight of the arcs, the treatment plan was optimized for 
each patient. The plans were normalized to 100% in the isocenter. The use of arcs 
rather than fixed-shaped fields resulted in a higher dose falloff around the targeted 
volume, that is, a lesser integral dose in the surrounding critical tissues.
Figure 1. Anterior view on an example of a highly conformal external beam radiotherapy treatment plan for an LAD coronary 
artery stent. The PTV surrounding the targeted stent-traversed volume during the cardiac cycle is depicted in red within the 
transparent WHV. Also depicted within the WHV are the nontargeted remainder of the LAD in blue, the LCx in green, and the RCA 
in purple.
The volume receiving ≥ the prescribed dose (V80) and the volume of the nontargeted 
major coronary arteries receiving ≥ 50% of the total dose (V50) were determined. 
The maximum dose (Dmax) to the two nontargeted major coronary arteries was 
also determined and is reported as a percentage of the total dose received by the 
targeted vessel.
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Endovascular brachytherapy dose distributions
The maximum dose to the nontargeted major coronary arteries for endovascular 
brachytherapy was calculated by measurement of the shortest spatial relationship 
between the respective vessel segments in a diastolic MSCT dataset. A curved 
source with a length of 20 mm was divided into short segments 1 mm in length. 
Each segment was considered as a point source (Pi). The contribution of this point 
source to the dose rate at a point Pr, i.e., DPi, in a nontargeted major coronary artery 
at a distance ri from the point source in the targeted stent is as follows (Eq. 1):
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Figure 2. Diagram of the strategy to determine the maximum dose to nontargeted major coronary arteries when a stented 
coronary artery segment is irradiated by an endovascular iridium source.
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where Ai (MBq) is the activity of the point source (1-mm segment), the conversion 
factor from kerma to dose in water f = 1.1, and the air kerma rate K0 = 0.10995 
µGy/hr/MBq at 1 meter distance. S(ri) describes the attenuation of the radiation 
by absorption and scattering with the constants δ = 1.018 and β = 0.6 x 10-3 cm2 
(Eq. 2), which are applicable for iridium (13). The total dose rate in point Pr is the 
summed contribution of all point sources (Figure 2). The reported doses in the 
adjacent arteries were normalized to the reference dose of 1 Gy at 2 mm from the 
axis in the central plane of the assumed 20-mm total source length (14).
Results
The WHV, which was contoured as part of the high-precision EBRT treatment 
planning process, was 834 ± 93 cm3 (range: 665–947 cm3). The target volume, that 
is, the STV during the cardiac cycle, was 1.2 ± 1.1 cm3 (range: 0.4–3.8 cm3) and 
represented ≤ 0.4% of the WHV in all patients. The PTV was 9.0 ± 6.0 cm3 (range: 
3.9–24.2 cm3) and represented ≤ 2.8% of the WHV in all patients. A volume of 
15.8 ± 8.8 cm3 (range: 5.7–35.1 cm3) received ≥ the prescribed dose when targeted 
by high-precision EBRT (Table 1). 
Table 1. Absolute and relative high-precision external beam radiotherapy treatment planning volumes.
Patient STV (cm3) PTV (cm3) V80 (cm
3) STV/WHV (%) PTV/WHV (%)
1 0.8 6.3 12.0 0.12 0.95
2 0.7 5.4 10.6 0.07 0.61
3 0.4 3.9 7.8 0.05 0.45
4 0.7 5.6 10.8 0.07 0.62
5 1.2 9.0 15.7 0.13 0.97
6 1.1 12.0 23.9 0.16 1.65
7 3.8 24.2 35.1 0.44 2.76
8 2.2 11.4 19.8 0.29 1.50
9 0.5 4.6 5.7 0.05 0.48
10 0.4 8.0 16.8 0.05 1.00
STV = stent traversed volume; PTV = planning target volume; V80 = volume receiving ≥ 80% of the total dose; WHV = whole heart volume.
High-precision EBRT resulted in a V50 of 0 cm
3 for both nontargeted major coronary 
arteries for six of the targeted vessels. The two targeted LCx stents resulted in a 
V50 of 0.04 cm
3 and 0.18 cm3 for the LAD (Patient 1 and 10, respectively), and two 
targeted LAD stents resulted in a V50 of 0.13 cm
3 and 0.04 cm3 for the LCx (Patient 
4 and 6, respectively).
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High-precision EBRT targeted at LCx stents contributed a mean Dmax of 83.5% 
(range: 71.6–95.3%) and 16.3% to the LAD and RCA, respectively. Targeted LAD 
stents contributed a mean Dmax of 39.3% (range: 14.5–94.8%) and 5.2% (range: 
0–13.4%) to the LCx and RCA, respectively. Targeted RCA stents contributed a 
mean Dmax of 6.2% (range: 0–12.4%) and 5.8% (range: 0–11.5%) to the LCx and 
LAD, respectively. Endovascular brachytherapy targeted at LCx stents contributed 
a mean Dmax of 1.7% (range: 0.7–2.7%) and 1.0% (range 0.6–1.4%) to the LAD 
and RCA, respectively. Targeted LAD stents contributed a mean Dmax of 5.2% 
(range: 0.5–11.4%) and 0.7% (range: 0.4–1.1%) to the LCx and RCA, respectively; 
targeted RCA stents contributed a mean Dmax of 0.3% (range: 0.2–0.5%) and 0.2% 
(range: 0.1–0.3%) to the LCx and LAD, respectively (Table 2).
As was anticipated, an inverse relationship between the dose received by the 
nontargeted major coronary arteries and their distance from the targeted coronary 
artery stent was observed for both high-precision EBRT and endovascular 
brachytherapy. High (maximum) doses in nontargeted vessels were associated with 
a proximal location of the targeted coronary artery stent in the LCx or LAD, i.e., 
segment 11 and 6 for the LCx and LAD, respectively (Table 2, Figure 3).
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Figure 3. (a) Lateral view on a high-precision EBRT treatment plan (arcs not shown) targeting the PTV depicted in red around 
an LCx coronary artery stent (Patient 1) closely situated (arrow) to the LAD coronary artery depicted in blue. The nontargeted 
remainder of the LCx is depicted in green, and the RCA is depicted in purple. (b) The corresponding dose-volume histogram 
shows that a high (maximum) dose was contributed to the LAD.
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Table 2. Maximum dose to nontargeted major coronary arteries as a percentage of the total dose received by the stented 
coronary artery segment targeted by either high-precision external beam radiotherapy or endovascular brachytherapy. 
Patient  External beam radiotherapy  Endovascular brachytherapy
  LCx LAD RCA  LCx LAD RCA
1 T.s. 11 71.6 16.3 T.s. 11 2.7 0.6
2 21.6 T.s. 7 10.4 2.7 T.s. 7 0.4
3 31.3 T.s. 7 0 2.7 T.s. 7 0.5
4 94.8 T.s. 6 0 11.4 T.s. 6 1.1
5 21.6 T.s. 7 0 5.6 T.s. 7 0.8
6 51.8 T.s. 6 7.6 8.4 T.s. 6 0.9
7 0 0 T.s. 2 0.2 0.1 T.s. 2
8 12.4 11.5 T.s. 2 0.5 0.3 T.s. 2
9 14.5 T.s. 7 13.4 0.5 T.s. 7 0.4
10  T.s. 11 95.3 16.3  T.s. 11 0.7 1.4
LCx = left circumflex; LAD = left anterior descending; RCA = right coronary artery; T.s. = targeted segment of the LCx, LAD and 
RCA according to the definitions on segmental anatomy by the American Heart Association (20).
Discussion
Although the doses to the nontargeted major coronary arteries were higher for 
high-precision EBRT compared to endovascular brachtytherapy, in essence these 
doses are expected to be clinically irrelevant. However, high (maximum) doses were 
observed when a coronary artery stent targeted by high-precision EBRT was closely 
situated to a nontargeted major coronary artery, which applies anatomically for the 
proximal LCx and LAD, because they both arise from the left main coronary artery 
(Table 2, Figure 3). The doses in neighboring nontargeted major coronary arteries 
must depend also on the displacement of the targeted vessel segment during the 
cardiac cycle, because both the motion pattern and amplitude of coronary arteries 
have been reported to vary substantially from patient to patient (15). The high 
(maximum) doses may be prevented by additional reduction of the target volume. 
Because we are already dealing with a small target volume, the high (maximum) 
doses to nontargeted coronary arteries should be prevented preferably by patient 
selection, that is, exclusion of patients on the basis of treatment planning results. 
For all such selected patients, high-precision EBRT may pose a feasible alternative 
to endovascular brachytherapy for the treatment of coronary artery in-stent 
restenosis. The former treatment technique offers several potential advantages, such 
as dose fractionation and flexibility to optimize the time of treatment in relation to 
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target cell proliferation after PTCA. Whether these and other advantages of high-
precision EBRT, such as improved dose homogeneity over a range of tissue depths, 
outweigh procedural complexity and duration remains to be established.
High-precision EBRT targeted at the STV during the cardiac cycle would 
substantially reduce the target volume in comparison to previous studies on EBRT 
targeted at virtually the entire heart. Schwartz et al. (4), for instance, reported 
a small increase of neointimal hyperplasia after a single or fractionated dose of 
4–8 Gy targeted at virtually the whole porcine heart. Myocardial fibrosis was also 
observed. Marijianowski et al. (3) reported no effect on neointimal hyperplasia 
after a single dose of 14 Gy targeted at the porcine heart; however, interstitial and 
perivascular fibrosis in the myocardium was observed. Because the whole heart 
received the prescribed dose, the authors argued that the side effects might be 
related to the irradiation technique. Recently Verheije et al. (5) reported reduced 
neointimal hyperplasia after a single dose of 21 Gy targeted at the whole porcine 
heart, but also incomplete re-endothelialization, as well as myocardial inflammation 
and fibrosis. The latter study provides evidence for the effectiveness of EBRT in 
preventing coronary artery in-stent restenosis. However, clinical implementation 
demands the prevention of side effects, which may be achieved by the application 
of high-precision EBRT. Similar to whole-heart EBRT, high-precision EBRT will 
need to be investigated in an animal model after its technical feasibility has been 
further refined. Exploration of high-precision EBRT may also be of use for the 
treatment of arterial venous bridge fistula, because recent data suggests that high, 
single radiation doses, i.e., ≥ 15 Gy, are needed to induce significant inhibition of 
neointimal proliferation (16). 
The STV is a measure mainly of the cardiac motion effect on coronary artery stent 
position throughout the cardiac cycle, because MSCT was performed during one 
breath hold. However, the position of a stent throughout the cardiac cycle is also 
greatly affected by respiratory motion. Because a minimal target volume is of the 
utmost importance, the respiratory motion effect may best be countered similarly 
to the way MSCT was performed, that is, during breath hold. This can be achieved 
by, for instance, the use of active breathing control, which allows temporary and 
reproducible immobilization of internal thoracic structures (17). The 3D PTV 
margin by which the STV was encompassed is anticipated to be adequate when 
high-precision EBRT treatment planning and treatment would be performed by use 
of active breathing control. The margin was derived from clinical experience with 
stereotactic radiotherapy of extracranial targets (9, 18) and has been shown to be 
adequate for lung and liver cancers when breathing mobility is reduced to 5 mm by 
applying mechanical abdominal pressure (19). 
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A shortcoming of this study relates to the fact that the dose distributions throughout 
the heart, both for high-precision EBRT and endovascular brachytherapy, were 
determined by use of a single diastolic MSCT dataset. As a result, the dynamic 
relationships among the different coronary arteries during the cardiac cycle were not 
dosimetrically accounted for; however, a significant effect should not be expected. 
Although the doses distributed throughout the heart were higher for high-
precision EBRT compared to endovascular brachtytherapy, these doses are expected 
to be clinically irrelevant when nontargeted major coronary arteries are not closely 
situated to the targeted vessel segment. These encouraging preliminary results 
warrant further investigation of high-precision EBRT as a potential alternative 
to endovascular brachytherapy for the treatment of coronary artery in-stent 
restenosis.
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Abstract
Eight patients with 12 lung tumors were scanned using respiratory-gated multislice 
spiral computed tomography (MSCT). In each patient 10 datasets equally distributed 
throughout consecutive respiratory cycles were retrospectively reconstructed 
from the acquired MSCT data. The tumors were contoured in each dataset. By 
three-dimensional matching of the 10 target volumes, lung tumor center of mass 
displacements throughout the consecutive respiratory cycles could be determined 
for each patient. Respiratory-gated MSCT can therefore be of use for conformal 
radiotherapy treatment planning imaging. 
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Introduction
The use of computed tomography (CT) imaging is essential for conformal 
radiotherapy treatment planning. In common clinical practice these CT scans 
are performed while the patient breathes freely. Thoracic and abdominal tumors 
can move as much as 35 millimeters with breathing (1). Because the CT scanners 
commonly applied for radiotherapy treatment planning are not designed to 
determine respiratory motion, the clinical target volume is encompassed by an 
empirical generalized margin to account for this periodic physiological motion 
effect. However, individualized margins, as opposed to generalized margins, are 
required for radiation treatment of target volumes affected by respiratory motion 
(2). With the introduction of multislice spiral computed tomography (MSCT) 
individualized determination of periodic physiological target volume motion has 
come within reach. These scanners permit high-speed scanning with a high in-plane 
and craniocaudal resolution (3). Leter et al. (4) described one of the first applications 
of MSCT within the field of radiotherapy. These authors used MSCT scans gated to 
the electrocardiogram (ECG) to define a potential radiotherapy target volume. The 
purpose of this study was to test whether the strategy described in the latter study 
could be applied for determination of respiratory lung tumor motion. 
Materials and methods 
Eight patients (6 men, 2 women; mean age, 55.5 years; age range, 46-65 years) with 
12 lung metastases, scheduled for a diagnostic thoracic CT, were included in this 
study. They were asked to participate by their referring physician. The University 
Hospital Ethical Review Board approved this study. All participants gave written 
informed consent.
Thoracic MSCT of the entire lung volume was performed using a 16-slice scanner 
(Sensation 16, Siemens, Forchheim, Germany) which provided a temporal resolution 
of 250 ms. The scanner allowed for the following parameters: 0.5-s rotation time, 
temporal resolution 250 ms (180° reconstruction algorithm), detector collimation 
16 x 1.5 mm, table feed 3.6 mm/rotation, tube voltage 120 kV and current 150 
mAs. The smallest pitch (table feed per rotation divided by the collimated width of 
the entire detector) the scanner allowed for at the time of the study was: 0.15.
During the scan patients were instructed to breath through a spirometer 
(MasterScope Color, Viasys Healthcare, Bilthoven, The Netherlands), connected to 
a laptop computer, and were fitted with a nose clip to prevent air leakage through the 
nostrils. To ensure multiphase detection of respiratory tumor motion without data 
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loss, the breathing cycles had to be limited to about 3 seconds. Audio prompting 
was used to optimize breathing regularity, i.e., the patient was instructed to perform 
inspiration and expiration at the 48 ticks per minute of a metronome. 
Because the spiral CT data was acquired continuously, a stack of overlapping slices 
can be reconstructed at any time point. For each patient ten stacks of 1.5 mm slices 
were reconstructed equally distributed throughout consecutive respiratory cycles 
by dedicated S16-SpiroRecon work-in-progress software (Siemens, Forchheim, 
Germany) from the acquired MSCT data on an off-line workstation. For this 
purpose the 250 ms reconstruction window was positioned from 0 to 100% of the 
respiratory cycles with 10% increments. The lung tumors were manually contoured 
at a window of 1500 Hounsfield units and a level of –500 Hounsfield units in all 
10 MSCT datasets of each patient using a custom-made tumor contouring and 
matching software program (Rotterdam, The Netherlands) developed by one of the 
authors (P.J.N.). An end-inspiratory tumor volume was selected as a reference and 
was consecutively matched by three-dimensional (3D) translation and rotation with 
the other nine volumes to determine the lung tumor center of mass displacements 
throughout the consecutive respiratory cycles. 
Results
All patients could cooperate with the breathing procedure. There was no exclusion 
of patients during the study period. The complete imaging procedure took 15 
minutes in the first 2 patients and was finished within 10 minutes in the remaining 
patients. The scan time was 43.7 ± 3.1 seconds (mean ± 1 standard deviation). The 
acquired imaging data provided adequate image quality for multiphase visualization 
of lung tumors. 
The mean reference tumor volume was 2.2 cm3 ± 17.3 cm3. The mean of the 
maximum 3D center of mass displacements between any two phases during the 
consecutive respiratory cycles for all 12 lung tumors are summarized in the Table. 
The maximum amplitude in the lateral direction was 2.2 ± 1.0 mm, 3.3 ± 1.4 mm 
in the ventrodorsal direction and 13.3 ± 7.4 mm in the craniocaudal direction.
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Table. Tumor locations and maximum amplitudes in the lateral (L), ventrodorsal (VD) and craniocaudal (CC) direction. 
Patient Tumor location Maximum amplitude of motion (mm)
  L VD CC
1 Upper lobe 1.2 2.9 8.0
2 Upper lobe 2.2 2.2 4.1
3A Lower lobe 3.1 5.5 20.8
3B Lower lobe 2.4 1.8 19.8
3C Upper lobe 1.9 4.7 7.5
3D Upper lobe 1.2 2.7 2.9
4 Lower lobe 2.9 3.7 14.4
5 Lower lobe 1.9 3.2 26.1
6A Lower lobe 1.9 5.8 15.0
6B Lower lobe 3.0 2.4 19.5
7 Upper lobe 4.5 3.0 6.6
8 Lower lobe 0.6 1.5 15.0
Discussion
It has recently been described how an ECG-gated MSCT imaging strategy could be 
used to determine cardiac motion of a potential radiotherapy target volume. The 
strategy entailed retrospective reconstruction of MSCT data during 10 selected 
phases equally distributed throughout the RR-interval of consecutive cardiac 
cycles. By the consideration of the fourth dimension, namely time, cardiac target 
volume motion could be determined (4). Our current results represent a successful 
application of this strategy for determination of respiratory lung tumor motion. 
The strategy allows individualized determination of margins to account for 
respiratory motion of any thoracic or abdominal target volume during treatment 
planning imaging. A method for obtaining such four-dimensional (4D) datasets 
of lung tumors has been described previously by Low et al. (5). These authors 
used sequential MSCT scans. We chose a less laborious strategy by spiral scans. 
Moreover, because our data was reconstructed relative to the scan start point, in 
principle the only requirement is a breathing motion measure that provides a clear 
start and end point of the respiratory cycle. 
The observed maximum motion amplitudes and the tendency of greater motion 
in the lower lobes (Table) concur with previous reports on respiratory motion of 
lung tumors (6, 7). Because of the small number of patients we could not provide 
motion data for the different lung lobes separately.
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Because of pitch limitations at the time of the study the duration of the respiratory 
cycles had to be limited to a maximum of 3 seconds. A lower pitch value is expected 
to be available in the near future. 
In conclusion, 4D MSCT datasets allowed determination of respiratory lung 
tumor displacements throughout consecutive respiratory cycles. The acquisition of 
such 4D spiral imaging datasets for radiotherapy purposes and their reproducibility 
warrants further investigation.
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Abstract
Purpose: We used four-dimensional multislice spiral computed tomography 
(MSCT) to determine respiratory lung tumor motion and compared this strategy to 
common clinical practice in conformal radiotherapy treatment planning imaging.
Methods and materials: The entire lung volume of 10 consecutive patients with 
14 lung metastases was scanned by a 16-slice MSCT. During the scan patients 
were instructed to breath through a spirometer that was connected to a laptop 
computer. For each patient 10 stacks of 1.5 mm slices were reconstructed equally 
distributed throughout the respiratory cycle from the acquired MSCT data. 
The lung tumors were manually contoured in each dataset. For each patient 
the tumor volume contours of all datasets were copied to one reference dataset, 
which allowed determination of the volume that encompassed all 10 lung tumor 
positions, i.e., the tumor traversed volume (TTV) during the respiratory cycle. The 
TTV was compared to the 10 tumor volumes contoured for each patient to which 
an empirical respiratory motion margin was added. The latter target volumes were 
designated internal motion included tumor volume (IMITV).
Results: The TTV measurements were significantly smaller than the reference IMITV 
measurements. In one patient all 10 IMITVs completely encompassed the TTV. In 
the remaining nine patients some of the 10 IMITVs completely encompassed the 
TTV and some did not show overlap with up to 35% of the TTV.
Conclusions: We found that individualized determination of respiratory lung tumor 
motion by four-dimensional respiratory-gated MSCT represents a better and simple 
strategy to incorporate periodic physiological motion compared to a generalized 
approach. The former strategy can therefore improve common and state-of-the-art 
clinical practice in conformal radiotherapy. 
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Introduction
Conformal radiotherapy (CRT) heavily depends on adequate imaging to allow 
accurate treatment planning for which computed tomography (CT) scans 
are required. During radiation treatment of thoracic and abdominal tumors 
physiological motion needs to be considered. Respiratory motion in particular and 
also cardiac motion are the main contributors to physiological motion within the 
treatment session (1). Because radiotherapy becomes increasingly conformal, the 
issue of respiratory and cardiac tumor motion becomes increasingly important (2). 
However, the single-slice CT scanners installed in most radiotherapy treatment 
planning units are not equipped to determine these periodic physiological motion 
effects. By use of these scanners the tumor volume is scanned at a random time 
point within the respiratory cycle under the assumption that the scan images 
represent the average position of the tumor, i.e., midway between inspiration 
and expiration. To account for periodic physiological motion in common clinical 
practice a generalized empirical 3D margin is subsequently added to the tumor 
volume. Alternatively, tumor motion can be determined as part of the treatment 
planning procedure for which fluoroscopy is most widely used. However, tumors are 
often poorly visualized by use of this imaging modality. In addition, determination 
of actual tumor motion is technically challenging by fluoroscopy and the data 
cannot directly be related to the treatment planning CT data. 
With the introduction of multislice spiral computed tomography (MSCT) scanners 
individualized determination of periodic physiological motion has come within 
reach. These scanners operate at an increased rotation rate and produce up to 64 
slices simultaneously as opposed to single-slice CT scanners and thereby permit 
high-speed scanning of large volumes with a high in-plane resolution, as well as an 
improved craniocaudal resolution and a substantial improvement in the inter-slice 
correlation (3). It is for these reasons MSCT scanners allow the addition of the 
fourth dimension, that is, time, to the 3D treatment planning imaging process. It has 
been reported, for instance, that MSCT gated to the electrocardiogram allows for 
determination of cardiac motion of a potential thoracic high-precision conformal 
radiotherapy target volume (4). 
Adapted from the latter study we used four-dimensional (4D) MSCT to determine 
respiratory lung tumor motion and compared this strategy to common clinical 
practice in CRT treatment planning imaging. 
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Methods and materials
Ten consecutive patients (8 men, 2 women; mean age, 58.0 years; age range, 46-73 
years) with 14 lung metastases scheduled for diagnostic thoracic CT examination 
were scanned. The University Hospital Ethical Review Board approved this study 
and all participants gave written informed consent.
Thoracic MSCT of the entire lung volume was performed by use of a 16-slice 
scanner (Sensation 16, Siemens, Forchheim, Germany) which provided a temporal 
resolution of 250 ms. The scanner allowed for the following parameters: 0.5-s 
rotation time, temporal resolution 250 ms (180° reconstruction algorithm), 
detector collimation 16 x 1.5 mm, table feed 3.6 mm/rotation, tube voltage 120 
kV and current 150 mAs. The smallest pitch (table feed per rotation divided by the 
collimated width of the entire detector) the scanner allowed for at the time of the 
study was: 0.15.
During the scan patients were instructed to breath through a spirometer 
(MasterScope Color, Viasys Healthcare, Bilthoven, The Netherlands), connected to 
a laptop computer, and were fitted with a nose clip to prevent air leakage through 
the nostrils. At the time of the study respiratory-gating could only be performed 
manually. To ensure multiphase detection of respiratory tumor motion without 
data loss, the breathing cycle had to be limited to about 3 seconds. With a table 
feed of 7.2 mm per second every z-position of the patient is registered by a detector 
slice for about 3 s (detector width 24 mm, 3 x 7.2 mm = 21.6 mm). Consequently, 
at every z-position data of an entire respiratory cycle is registered. Audio prompting 
was used to optimize breathing regularity, i.e., the patient was instructed to perform 
inspiration and expiration at the 48 ticks per minute of a metronome. Therefore 
the frequency of respiration ranged around 24 per minute.
Because the spiral CT data was acquired continuously, a stack of overlapping 
slices can be reconstructed at any time point. For each patient ten stacks of 1.5 
mm slices were reconstructed equally distributed throughout the respiratory cycle 
by dedicated S16-SpiroRecon work-in-progress software (Siemens, Forchheim, 
Germany) from the acquired MSCT data on an off-line workstation. For this 
purpose the 250 ms reconstruction window was positioned from 0 to 100% of the 
respiratory cycle with 10% increments (Figure 1). 
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Figure 1. Diagram of the strategy for retrospective reconstruction of 10 multislice spiral computed tomography (MSCT) image 
datasets equally distributed throughout the respiratory cycle. 
The lung tumors were manually contoured at a window of 1500 Hounsfield units 
and a level of –500 Hounsfield units in all 10 MSCT datasets of each patient 
by use of a custom-made tumor contouring software program (Rotterdam, The 
Netherlands) developed by one of the authors (P.J.N.). An end-inspiratory tumor 
volume was selected as a reference. For each patient the tumor volume contours of 
all datasets were copied to the reference dataset, which allowed determination of 
the volume that encompassed all 10 lung tumor positions, i.e., the tumor traversed 
volume (TTV) during the respiratory cycle. The TTV was compared to the 10 
tumor volumes contoured for each patient to which an empirical 0.5 cm transversal 
and 1 cm craniocaudal margin for lower lobe tumors and a symmetrical 3D 0.5 cm 
margin for upper lobe tumors was added. The latter target volumes were designated 
internal motion included tumor volume (IMITV), each of which could represent 
a randomly scanned target volume during the respiratory cycle (Figure 2). The 
empirical margins around these tumor volumes were considered to be adequate 
on the basis of respiratory motion data reported by Seppenwoolde et al. (5) who 
studied 3D marker motion implanted in or near lung neoplasms by a real-time 
tumor tracking system using two fluoroscopy image processor units. 
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II
I
IMITV-I
TTV
IMITV-II
Figure 2. Diagram shows the difference between four-dimensional respiratory-gated lung tumor definition and common 
clinical practice in conformal radiotherapy, i.e., a tumor scanned at a random time point and encompassed by a generalized 
empirical respiratory motion margin. For clarity only two tumor positions (I, II) are depicted within the tumor traversed volume 
(TTV) during the respiratory cycle. The corresponding internal motion included tumor volumes (IMITVs) for the two tumor 
positions are also depicted.
The paired t test was used to test the difference between the TTV and reference 
IMITV measurements. A value of P < 0.05 was considered significant.
Results
The complete imaging procedure took 10-15 minutes and was performed successfully 
and without complications in all patients. The scan time was 42.9 ± 3.0 seconds 
(mean ± 1 standard deviation). Respiratory-gated MSCT provided adequate image 
quality for multiphase visualization of lung tumors (Figure 3). Seven tumors were 
situated in the upper lobe and the remaining seven in the lower lung lobe. None of 
the neoplasms was attached to surrounding rigid structures.
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A B
Figure 3. Example of two four-dimensional respiratory-gated multislice spiral computed tomography volumes with a coronal 
plane at different time points (A, B) within the respiratory cycle. The corresponding positions of the right lower lobe lung tumor 
are shown. 
The mean reference tumor volume was 2.5 ± 16.9 cm3. The TTV measurements 
were significantly smaller than the reference IMITV measurements. In one patient 
all 10 IMITVs completely encompassed the TTV. In the remaining nine patients 
some of the 10 IMITVs completely encompassed the TTV and some showed an 
incomplete overlap with the TTV of up to 35%. 
Discussion
This study shows to what extent a generalized empirical margin around a 
thoracic target volume to account for respiratory motion, can be arbitrary for 
the individual patient. We found a geometrical discrepancy between the IMITVs 
and the corresponding TTV in all patients. This discrepancy is partly explained 
by the difference in size between the respective target volumes, which could result 
in unnecessary dose to healthy tissue. However, when the tumor is scanned at a 
random time point within the respiratory cycle it is possible that a tumor position 
at the boundaries of the TTV is used for treatment planning (Figure 2). This partly 
also explains our findings because some of the IMITVs in nine patients did not 
show overlap with up to 35% of the TTV. Treatment planning on the basis of such 
a tumor position could not only result in unnecessary dose to healthy tissue but also 
inadequate dose to the target. Moreover, the empirical margins used in this study are 
far from an overestimation of the extent of respiratory motion, particularly in the 
craniocaudal direction for lower lobe tumors (5). Individualized determination of 
respiratory motion by 4D MSCT for CRT treatment planning therefore represents 
a better and simple strategy to incorporate periodic physiological motion of lung 
tumors compared to a generalized approach and can allow improvement of the 
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therapeutic ratio. However, such a 4D imaging strategy will demand an additional 
margin for microscopic extension and other treatment uncertainties.
Although the reduction of the respiratory motion effect 4D respiratory-gated 
MSCT allows for may be limited in comparison to novel treatment techniques 
such as triggered high-precision CRT (6), tumor tracking (7) and breath-holding 
techniques (8, 9), the difference may not necessarily reflect clinical relevance. 
Irradiation of the TTV may therefore represent the best trade-off between the 
therapeutic ratio and technical and logistic efforts. Nevertheless, 4D respiratory-
gated MSCT will be useful for the afore-mentioned novel treatment techniques, 
e.g., to determine residual breathing motion when active and passive breath-
hold techniques are applied, to identify the respiratory phase of minimal tumor 
motion for each patient individually and to determine residual motion within this 
interval for triggered high-precision CRT, and to provide the basis for 4D tumor 
tracking radiotherapy planning and delivery. Moreover, 4D MSCT is applicable for 
abdominal and pelvic target volumes and simultaneous determination of cardiac 
motion by additional ECG-gating is anticipated to be feasible. 
Alternative methods have been described for obtaining 4D datasets. Ford et al. 
(10) and Vedam et al. (11) used a single-slice CT scanner to acquire a 4D dataset 
of a motion target phantom. The latter authors also scanned a lung cancer patient. 
The spatial and temporal resolution was limited in both studies inherent to the 
use of a single-slice CT scanner. Low et al. (12) used a four-slice MSCT scanner 
in the cine mode to acquire 15 scans at 23-26 successive couch positions for a 
4D image dataset of the entire thorax in three lung cancer patients. In the light 
of the specifications of the latest generation of MSCT scanners, we chose for a 
different, simpler and less time-consuming strategy to acquire 4D respiratory-gated 
image datasets adapted from the previously described strategy to determine cardiac 
motion of a potential high-precision CRT thoracic target volume (4).
Because of the specifications of the MSCT scanner at the time of the study, 
the duration of the respiratory cycle had to be limited to about 3 seconds. An 
improvement of these specifications is expected to be available in the near future 
and will allow patients to breath at their normal frequency during 4D respiratory-
gated MSCT scans. 
Because the frequency and amplitude of respiration varies over time (2) it 
is important for any application of 4D respiratory-gated MSCT to establish 
whether target volume determination is reproducible over time. Although not the 
subject of the current study it seems a fair anticipation that the TTV will be more 
representative over time than the IMITV because the random acquisition of the 
latter results in additional uncertainty compared to the former. Training patients 
to improve breathing regularity using audio prompting to the breathing frequency 
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and visual feedback of the respiratory trace (13) will be of paramount importance 
for radiotherapy on the basis of 4D respiratory-gated MSCT. During our study 
respiratory-gating was performed manually. This did not represent a problem 
because data was reconstructed relative to the scan start point. It is for this reason 
also that definition of the TTV does not demand spirometry, i.e., in principle the 
only requirement is a breathing motion measure that provides a clear start and end 
point of the respiratory cycle.
Although our findings are preliminary they strongly suggest that 4D respiratory-
gated MSCT can improve common and state-of-the-art clinical practice in CRT. 
Future study is warranted to further explore the advantages MSCT offers for high-
precision CRT including combinations with other imaging modalities, e.g., magnetic 
resonance imaging or positron emission tomography, and efficient strategies to 
facilitate treatment planning of 4D image datasets.
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Due to technological developments, the conformality of external beam radiotherapy 
(EBRT) has increased substantially. Hence, there is a growing need to accurately 
account for geometrical uncertainties such as organ motion and patient and beam 
set-up deviations. Respiratory and cardiac motion are the main contributors to 
intra-fraction positional variations of thoracic and abdominal target volumes. 
This thesis describes the development of strategies to deal with these periodic 
physiological motion effects for each patient individually. State-of-the-art imaging 
techniques have been used to better account for the fourth dimension, namely time, 
in the 3D CRT process.
Biplane angiography to determine and incorporate cardiac target volume motion 
Intravascular brachytherapy is an effective treatment for the prevention of coronary 
artery de novo and in-stent restenosis. However, intravascular brachytherapy 
suffers from several radiobiological, clinical, physical and logistic disadvantages 
that may be circumvented by the use of an EBRT technique. Embedded in the 
general aim of this thesis, investigation of the clinical feasibility of CRT for the 
prevention of coronary artery in-stent restenosis, as an alternative to intravascular 
brachytherapy, represented an excellent study model. In chapter 2 it is demonstrated 
that 3D reconstructions derived from biplane angiograms synchronized to the 
electrocardiogram (ECG) can be used to accurately determine the volume through 
which a coronary artery stent traverses during the cardiac cycle. This volume, less 
than 0.8% of the whole heart volume, represents a potential target volume for 
CRT. In chapter 3 it is established that the coronary artery stent traversed volume 
(STV), as determined by ECG-synchronized biplane angiograms, can be reduced 
significantly when defined during the systole, diastole or 160–480 ms intervals 
within the cardiac cycle.
Because biplane X-ray imaging data are not directly compatible with EBRT 
treatment planning systems, it was attempted to apply the afore-mentioned strategy 
using CT scans.
MSCT to determine and incorporate cardiac target volume motion 
CT scanners commonly applied for radiotherapy treatment planning are not designed 
to determine respiratory and cardiac motion. With the introduction of MSCT 
scanners, the afore-mentioned limitation can be overcome. In chapter 4, the 3D 
positional variation of coronary artery stents in patients immobilized in a stereotactic 
body frame was studied by single-breath hold ECG-gated MSCT. Reconstructions 
were acquired for 10 retrospectively selected phases equally distributed throughout 
the R-R interval of the cardiac cycle. The volume encompassing all 3D positions of 
a stent could be determined as a measure of the STV during the cardiac cycle. The 
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STV represented less than 0.6% of the whole heart volume in the studied patients. 
Chapter 5 describes the results of a dosimetric comparison between intravascular 
brachytherapy targeted at a stented coronary artery segment, and EBRT targeted 
at the STV during the cardiac cycle as determined by ECG-gated MSCT. An EBRT 
treatment plan was created for stents in the left circumflex (LCx), left anterior 
descending (LAD), and right coronary artery (RCA). The doses distributed 
throughout the heart were higher for EBRT. However, these increased doses are 
expected to be clinically irrelevant when nontargeted major coronary arteries are 
not closely situated to the targeted vessel segment.
Both biplane angiography and MSCT allow definition of the coronary artery STV 
during the cardiac cycle as a relatively small potential target volume for CRT. 
The most challenging technical obstacle in studying the feasibility of CRT for the 
treatment of coronary artery in-stent restenosis thereby is overcome. However, the 
use of radiotherapy for the afore-mentioned purpose has been reduced substantially 
because new treatment techniques have emerged. 
The described imaging strategies to account for cardiac motion can be applied for 
any thoracic or upper abdominal target volume.
MSCT to determine and incorporate respiratory target volume motion 
Chapter 6 reports on a study of patients with lung tumors who were scanned using 
4D respiratory-gated MSCT. For each patient 10 MSCT datasets equally distributed 
throughout consecutive respiratory cycles were retrospectively reconstructed from 
the acquired MSCT data. The maximum amplitude of the lung tumor center 
of mass displacements throughout the respiratory cycle was 2.2 ± 1.0 (mean ± 
standard deviation) mm in the lateral direction, 3.3 ± 1.4 mm in the ventrodorsal 
direction and 13.3 ± 7.4 mm in the craniocaudal direction. Chapter 7 describes a 
comparison between a generalized 3D and an individualized 4D MSCT imaging 
strategy to account for respiratory lung tumor motion. A geometrical discrepancy 
between the former and latter strategy was found. Individualized determination of 
respiratory lung tumor motion by 4D respiratory-gated MSCT represents a better 
and simple strategy to incorporate periodic physiological motion compared to a 
generalized approach. The 4D MSCT technique to account for respiratory motion 
can be applied for any thoracic or abdominal target volume.
The studies in this thesis mainly focus on the advantages for CRT of 4D MSCT 
gated to periodic physiological motion. Target volumes affected by respiratory 
and cardiac motion can benefit the most from this imaging strategy. Moreover, 
4D MSCT gated to periodic physiological motion can also be useful for novel 
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treatment techniques such as gated, tumor tracking and breath holding CRT. Four-
dimensional imaging by MSCT can therefore improve routine and state-of-the-art 
clinical practice in radiotherapy. Future studies on the use of 4D MSCT in CRT 
should include exploration of the combination with other imaging modalities such 
as magnetic resonance imaging, and on efficient strategies to facilitate treatment 
planning using 4D imaging datasets.
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Conformatieradiotherapie is een vorm van uitwendige radiotherapie. Deze behan-
deltechniek beoogt nauwkeurige bestraling van het doelvolume, terwijl gezonde 
omliggende weefsels en organen zoveel mogelijk worden ontzien. Hiertoe wordt 
tijdens de voorbereiding van conformatieradiotherapie met behulp van een compu-
tertomografie (CT) scanner de driedimensionale omvang en ligging van het doel-
volume bepaald. Door technische ontwikkelingen wordt conformatieradiotherapie 
steeds nauwkeuriger toegepast. Hierdoor wordt het toenemend belangrijk om reke-
ning te houden met factoren die de behandelnauwkeurigheid kunnen beïnvloeden. 
Voorbeelden van deze factoren zijn de ademhaling en hartslag en kleine verplaat-
singen van de patiënt tijdens de bestraling. 
In de regel wordt de totale stralingsdosis over een aantal dagen verdeeld in 
zogenoemde fracties. Zo’n bestralingsfractie duurt doorgaans enkele minuten. 
Tijdens de bestraling van doelvolumina in de borstholte en buik beïnvloeden met 
name de ademhaling en hartslag de nauwkeurigheid van de behandeling. Het is 
gebruikelijk dat de patiënt doorademt tijdens een bestralingsfractie. Een bestra-
lingsplan gebaseerd op een enkele conventionele CT scan van een doelvolume in 
de borstholte of buik, houdt daarom geen rekening met de invloed van de adem-
haling en hartslag. Tijdens de gangbare toepassing van conformatieradiotherapie 
wordt deze beperking gecompenseerd door voor iedere patiënt het betreffende 
doelvolume uit te breiden met een vaste driedimensionale marge. Deze marge is 
empirisch bepaald en niet afgestemd op de individuele patiënt. Hierdoor is de 
kans groot dat het doelvolume te weinig stralingsdosis ontvangt en de omlig-
gende gezonde weefsels en organen juist teveel. 
In dit proefschrift worden geavanceerde beeldvormingsstrategieën beschreven 
waarmee voor iedere patiënt individueel de invloed van de ademhaling en hartslag 
kan worden bepaald en geïntegreerd in het doelvolume. Met deze strategieën is 
het mogelijk voor iedere patiënt individueel, nauwkeurig rekening te houden met 
de vierde dimensie. Namelijk de invloed van tijd op de positie van het doelvolume 
tijdens de bestralingsfractie. 
Vierdimensionale röntgendoorlichting voor de bepaling en integratie van door de hartslag veroorzaakte 
doelvolumebeweeglijkheid
Een dotterbehandeling komt in aanmerking bij pijnklachten door een vernauwing 
in de kransslagader. Helaas komt binnen enkele weken of maanden in een derde van 
de geslaagde behandelingen de vernauwing terug. Deze hervernauwing noemt men 
restenose. Plaatsing van een conventionele stent in de kransslagader vermindert de 
kans op restenose enigszins. Een stent is een metalen veertje dat in de kransslagader 
kan worden gebracht om het bloedvat open te helpen houden. Nieuwe behande-
lingsmethoden zijn ontwikkeld om de kans op restenose nog verder te verminderen. 
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Eén van deze nieuwe ontwikkelingen is het bestralen van de plaats van de dotter-
behandeling met een speciale catheter die een inwendige stralingsbron bevat. Deze 
behandeltechniek wordt intravasculaire brachytherapie genoemd. Intravasculaire 
brachytherapie is een effectieve therapie om restenose aanzienlijk te beperken. Deze 
invasieve, inwendige vorm van radiotherapie heeft echter een aantal nadelen die in 
mindere mate gelden voor uitwendige radiotherapie. De laatstgenoemde behan-
delwijze maakt het bijvoorbeeld mogelijk de dosis te fractioneren, terwijl dit met 
brachytherapie geen reële optie is. Een studie naar de technische haalbaarheid van 
uitwendige radiotherapie ter behandeling van restenose in kransslagaderstents, 
vormde een geschikt model binnen de doelstelling van dit proefschrift. In hoofd-
stuk 2 wordt aangetoond dat met hartfilm-gecorreleerde vierdimensionale rönt-
gendoorlichtingsbeelden, de door de hartslag veroorzaakte beweeglijkheid van het 
doelvolume nauwkeurig kan worden bepaald. Deze beweeglijkheid is geïntegreerd 
tot het door de stent doorkruiste volume onder invloed van de hartslag. Dit door 
de stent doorkruiste volume vormde minder dan 0.8% van het gehele hartvolume 
en kan hiermee worden beschouwd als een potentieel doelvolume voor uitwendige 
radiotherapie. In hoofdstuk 3 wordt beschreven dat een dergelijk door de stent 
doorkruist volume significant kan worden gereduceerd wanneer het wordt bepaald 
tijdens een deel van de hartslag. 
Omdat vierdimensionale röntgendoorlichtingsbeelden niet rechtstreeks gebruikt 
kunnen worden voor een bestralingsplan, is getracht de beschreven strategie met 
behulp van een geavanceerde CT-scanner te verrichten.
Multislice spiraal computertomografie voor de bepaling en integratie van door de hartslag veroorzaakte 
doelvolumebeweeglijkheid 
De röntgenbron en het detectorsysteem in het type CT scanners geïnstalleerd op de 
meeste radiotherapieafdelingen, draaien continu rondom de patiënt waarbij coupe 
voor coupe wordt gescand. Door de te lange beeldacquisitietijden zijn deze scanners 
niet geschikt voor het bepalen van de invloed van de ademhaling en hartslag op 
de beweeglijkheid van doelvolumina in de borstholte en buik. Met de introductie 
van zogenoemde multislice spiraal computertomografie (MSCT) scanners is dit wel 
mogelijk geworden. Met deze techniek kunnen namelijk meerdere coupes tegelijk 
gescand worden en kan sneller gescand worden. In hoofdstuk 4 wordt aangetoond 
dat de door de hartslag veroorzaakte variatie in de driedimensionale positie van 
kransslagaderstents, kan worden bepaald met vierdimensionale MSCT. Hiertoe 
is de hartfilm-gecorreleerde beeldvormingsinformatie behorende bij 10 gelijk over 
de hartcyclus verdeelde fasen retrospectief geselecteerd. Vervolgens is tijdens de 
verschillende fasen de corresponderende driedimensionale positie van de stent 
bepaald. Integratie van deze stentposities vormde een maat voor het door de stent 
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doorkruiste volume onder invloed van de hartslag. Dit potentiële doelvolume voor 
conformatieradiotherapie vormde minder dan 0.6% van het gehele hartvolume 
van de onderzochte patiënten. In hoofdstuk 5 worden de dosimetrische verschillen 
beschreven tussen een inwendig bestralingsplan gericht op een kransslagaderstent 
en een uitwendig bestralingsplan gericht op een doelvolume als beschreven in 
hoofdstuk 4. Weliswaar bleken de doses in het hart met uitwendige radiotherapie 
hoger, maar naar verwachting niet zodanig dat sprake is van klinische relevantie. 
Met zowel röntgendoorlichtingsbeelden als MSCT scans is het mogelijk gebleken 
de door de hartslag van patiënten veroorzaakte beweeglijkheid van kransslagader-
stents te bepalen. Het tijdens de hartcyclus door de stent doorkruiste volume is 
een integratie van deze beweeglijkheid en vormt een relatief klein potentieel doel-
volume. Uitwendige radiotherapie ter behandeling van restenose in kransslagader-
stents kan hierdoor technisch haalbaar worden geacht. Echter, het gebruik van 
radiotherapie voor de genoemde toepassing is sterk afgenomen vanwege nieuwe 
behandelmogelijkheden. 
De beschreven beeldvormingsstrategieën zijn toepasbaar voor ieder onder invloed 
van de hartslag beweeglijk doelvolume in de borstholte en bovenbuik.
Multislice spiraal computertomografie voor de bepaling en integratie van door de ademhaling 
veroorzaakte doelvolumebeweeglijkheid 
Hoofdstuk 6 beschrijft een studie van patiënten met longtumoren. Met vierdimen-
sionale MSCT scans, retrospectief gecorreleerd met 10 over de ademhalingscyclus 
gelijk verdeelde fasen, is de beweeglijkheid van longtumoren bepaald. De gemid-
delde maximale uitslag van de tumor, veroorzaakt door de ademhaling, was 13.3 
mm (standaard deviatie [SD] 7.4 mm) in de lengterichting van de patiënt, 3.3 
mm (SD 1.4 mm) in de voorachterwaartse richting en 2.2 mm (SD 1.0 mm) in de 
zijwaartse richting. Hoofdstuk 7 beschrijft een studie waarin beeldvorming met 
conventionele CT scans tijdens de voorbereiding van gangbare conformatieradio-
therapie, wordt vergeleken met de als in hoofdstuk 6 beschreven vierdimensionale 
beeldvorming met MSCT scans. De gangbare methode betrof uitbreiding van de 
longtumorposities met een empirische marge. De vierdimensionale methode betrof 
integratie van de bepaalde beweeglijkheid tot het door de longtumor doorkruiste 
volume tijdens de ademhalingscyclus. Beeldvorming volgens de gangbare praktijk 
resulteerde in een significant groter doelvolume dan het door de longtumor door-
kruiste volume onder invloed van de ademhaling. Eerstgenoemd doelvolume over-
lapte laatstgenoemd doelvolume geheel of gedeeltelijk. Vergeleken met de gangba-
re praktijk in de conformatieradiotherapie is vierdimensionale beeldvorming een 
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betere basis voor precisiebestraling. Het is toepasbaar voor ieder onder invloed 
van de ademhaling beweeglijk doelvolume in de borstholte en buik. 
De studies in dit proefschrift richten zich met name op de voordelen van retrospectief 
met de ademhaling of hartslag gecorreleerde vierdimensionale MSCT binnen de 
conformatieradiotherapie. De beschreven technieken zijn vooral toepasbaar bij 
patiënten met doelvolumina die onder invloed van de genoemde fysiologische effecten 
beweeglijkheid tonen. Tevens kan vierdimensionale MSCT van nut zijn voor andere 
nieuwe behandelingstechnieken zoals “triggered”, “tumor tracking” en “breath 
holding” conformatieradiotherapie. Toekomstige studies dienen zich te richten op 
methoden waarmee de voordelen van deze beeldvormingstechniek kunnen worden 
geoptimaliseerd voor radiotherapeutische toepassingen: gecombineerd gebruik met 
andere beeldvormingstechnieken, zoals MRI-scans. En efficiënte strategieën om 
vierdimensionale beeldvormingsinformatie te verwerken tijdens het vervaardigen 
van een bestralingsplan. 
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